| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.669 | 0.003 | 0.871 | Alpha-N-acetylglucosaminidase inhibitor | 0.748 0.003 DBMET01436 0.871 0.001 DBMET01437 0.652 0.003 DB09157 0.581 0.004 DBMET03364 0.605 0.004 DBMET00507 | DBMET01437 | |
| 0.617 | 0.017 | 0.846 | Aldehyde oxidase inhibitor | 0.699 0.008 DBMET01436 0.846 0.004 DBMET01437 0.57 0.023 DB09157 0.626 0.016 DBMET03364 0.586 0.021 DBMET00507 | DBMET01437 | |
| 0.582 | 0.009 | 0.63 | GABA C receptor rho-3 antagonist | 0.63 0.005 DBMET01436 0.573 0.011 DBMET01437 0.614 0.006 DB09157 0.611 0.006 DBMET03364 0.608 0.007 DBMET00507 | DBMET01436 | |
| 0.505 | 0.009 | 0.624 | Peroxidase inhibitor | 0.579 0.005 DBMET01436 0.595 0.005 DBMET01437 0.481 0.011 DB09157 0.496 0.01 DBMET03364 0.624 0.004 DBMET00507 | DBMET00507 | |
| 0.517 | 0.027 | 0.704 | 5 Hydroxytryptamine release inhibitor | 0.586 0.013 DBMET01436 0.704 0.004 DBMET01437 0.496 0.034 DB09157 0.529 0.024 DBMET03364 0.538 0.022 DBMET00507 | DBMET01437 | |
| 0.514 | 0.028 | 0.579 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.556 0.015 DBMET01436 0.579 0.01 DBMET01437 0.536 0.02 DB09157 0.549 0.016 DBMET03364 0.489 0.039 DBMET00507 | DBMET01437 | |
| 0.471 | 0.005 | 0.56 | 5 Hydroxytryptamine uptake stimulant | 0.524 0.004 DBMET01436 0.56 0.003 DBMET01437 0.427 0.01 DB09157 0.485 0.005 DBMET03364 0.416 0.012 DBMET00507 | DBMET01437 | |
| 0.458 | 0.004 | 0.915 | Alcohol oxidase inhibitor | 0.707 0.003 DBMET01436 0.915 0.002 DBMET01437 0.359 0.004 DB09157 0.406 0.004 DBMET03364 0.191 0.007 DBMET00507 | DBMET01437 | |
| 0.482 | 0.035 | 0.548 | Calcium channel L-type activator | 0.548 0.014 DBMET01436 0.542 0.015 DBMET01437 0.4 0.081 DBMET03364 0.397 0.083 DBMET00507 | DBMET01436 | |
| 0.448 | 0.004 | 0.721 | GABA C receptor agonist | 0.534 0.003 DBMET01436 0.721 0.002 DBMET01437 0.526 0.003 DB09157 0.541 0.003 DBMET03364 0.519 0.004 DBMET00507 | DBMET01437 | |
| 0.471 | 0.04 | 0.682 | Histamine release inhibitor | 0.531 0.02 DBMET01436 0.682 0.005 DBMET01437 0.411 0.07 DB09157 0.438 0.056 DBMET03364 0.523 0.022 DBMET00507 | DBMET01437 | |
| 0.432 | 0.003 | 0.611 | Ferrochelatase inhibitor | 0.49 0.003 DBMET01436 0.611 0.002 DBMET01437 0.398 0.004 DB09157 0.37 0.004 DBMET03364 0.351 0.005 DBMET00507 | DBMET01437 | |
| 0.489 | 0.064 | 0.617 | Caspase 9 stimulant | 0.613 0.034 DBMET01436 0.462 0.077 DBMET01437 0.468 0.074 DB09157 0.617 0.034 DBMET03364 0.39 0.117 DBMET00507 | DBMET03364 | |
| 0.434 | 0.021 | 0.697 | Superoxide dismutase inhibitor | 0.537 0.01 DBMET01436 0.697 0.004 DBMET01437 0.378 0.031 DB09157 0.438 0.02 DBMET03364 0.508 0.012 DBMET00507 | DBMET01437 | |
| 0.426 | 0.041 | 0.668 | 5 Hydroxytryptamine release stimulant | 0.539 0.021 DBMET01436 0.483 0.03 DBMET01437 0.537 0.022 DB09157 0.668 0.009 DBMET03364 0.28 0.076 DBMET00507 | DBMET03364 | |
| 0.424 | 0.045 | 0.67 | Cholesterol antagonist | 0.541 0.026 DBMET01436 0.67 0.01 DBMET01437 0.333 0.072 DB09157 0.369 0.057 DBMET03364 0.422 0.045 DBMET00507 | DBMET01437 | |
| 0.376 | 0.004 | 0.765 | Porphobilinogen synthase inhibitor | 0.519 0.003 DBMET01436 0.765 0.002 DBMET01437 0.287 0.005 DB09157 0.292 0.005 DBMET03364 0.336 0.005 DBMET00507 | DBMET01437 | |
| 0.392 | 0.027 | 0.443 | Calcium channel activator | 0.443 0.013 DBMET01436 0.429 0.016 DBMET01437 0.38 0.033 DB09157 0.405 0.023 DBMET03364 0.282 0.111 DBMET00507 | DBMET01436 | |
| 0.365 | 0.013 | 0.526 | Tyrosine 3 hydroxylase inhibitor | 0.417 0.006 DBMET01436 0.418 0.006 DBMET01437 0.394 0.009 DB09157 0.446 0.005 DBMET03364 0.526 0.004 DBMET00507 | DBMET00507 | |
| 0.349 | 0.004 | 0.368 | Keratolytic | 0.216 0.007 DBMET01436 0.368 0.003 DBMET01437 0.108 0.026 DB09157 0.127 0.019 DBMET03364 0.127 0.019 DBMET00507 | DBMET01437 | |
| 0.411 | 0.072 | 0.435 | Antibacterial | 0.368 0.092 DBMET01436 0.435 0.062 DBMET01437 0.393 0.08 DBMET03364 0.243 0.184 DBMET00507 | DBMET01437 | |
| 0.342 | 0.004 | 0.589 | Triose-phosphate isomerase inhibitor | 0.416 0.003 DBMET01436 0.589 0.002 DBMET01437 0.296 0.005 DB09157 0.274 0.005 DBMET03364 0.245 0.007 DBMET00507 | DBMET01437 | |
| 0.343 | 0.008 | 0.469 | UDP-glucose 4-epimerase inhibitor | 0.396 0.006 DBMET01436 0.469 0.003 DBMET01437 0.335 0.009 DB09157 0.321 0.009 DBMET03364 0.15 0.029 DBMET00507 | DBMET01437 | |
| 0.334 | 0.007 | 0.593 | Succinate dehydrogenase inhibitor | 0.389 0.004 DBMET01436 0.593 0.003 DBMET01437 0.317 0.008 DB09157 0.318 0.008 DBMET03364 0.308 0.009 DBMET00507 | DBMET01437 | |
| 0.324 | 0.005 | 0.515 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.395 0.004 DBMET01436 0.515 0.002 DBMET01437 0.273 0.008 DB09157 0.351 0.004 DBMET03364 0.207 0.015 DBMET00507 | DBMET01437 | |
| 0.339 | 0.038 | 0.394 | Insulysin inhibitor | 0.351 0.034 DBMET01436 0.386 0.024 DBMET01437 0.297 0.06 DB09157 0.337 0.039 DBMET03364 0.394 0.023 DBMET00507 | DBMET00507 | |
| 0.266 | 0.009 | 0.39 | Adenylate kinase inhibitor | 0.314 0.006 DBMET01436 0.39 0.003 DBMET01437 0.277 0.008 DB09157 0.235 0.011 DBMET03364 0.254 0.01 DBMET00507 | DBMET01437 | |
| 0.266 | 0.009 | 0.316 | GABA C receptor rho-2 antagonist | 0.316 0.005 DBMET01436 0.282 0.007 DBMET01437 0.273 0.008 DB09157 0.295 0.006 DBMET03364 0.289 0.006 DBMET00507 | DBMET01436 | |
| 0.298 | 0.044 | 0.404 | DNA synthesis inhibitor | 0.307 0.041 DBMET01436 0.404 0.021 DBMET01437 0.287 0.048 DB09157 0.309 0.041 DBMET03364 0.309 0.041 DBMET00507 | DBMET01437 | |
| 0.301 | 0.047 | 0.425 | Interleukin agonist | 0.358 0.027 DBMET01436 0.425 0.015 DBMET01437 0.288 0.054 DB09157 0.315 0.041 DBMET03364 0.345 0.03 DBMET00507 | DBMET01437 | |
| 0.288 | 0.036 | 0.44 | Anesthetic general | 0.391 0.018 DBMET01436 0.44 0.012 DBMET01437 0.256 0.048 DB09157 0.394 0.017 DBMET03364 0.175 0.091 DBMET00507 | DBMET01437 | |
| 0.291 | 0.039 | 0.381 | Gastrin inhibitor | 0.328 0.018 DBMET01436 0.361 0.008 DBMET01437 0.275 0.053 DB09157 0.299 0.034 DBMET03364 0.381 0.005 DBMET00507 | DBMET00507 | |
| 0.268 | 0.02 | 0.315 | 3C-like protease (Human coronavirus) inhibitor | 0.315 0.009 DBMET01436 0.312 0.009 DBMET01437 0.219 0.042 DB09157 0.237 0.033 DBMET03364 0.198 0.053 DBMET00507 | DBMET01436 | |
| 0.252 | 0.004 | 0.426 | Biliverdin reductase inhibitor | 0.305 0.003 DBMET01436 0.426 0.002 DBMET01437 0.208 0.005 DB09157 0.179 0.007 DBMET03364 0.178 0.007 DBMET00507 | DBMET01437 | |
| 0.272 | 0.033 | 0.363 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.32 0.018 DBMET01436 0.363 0.011 DBMET01437 0.269 0.034 DB09157 0.282 0.03 DBMET03364 0.273 0.033 DBMET00507 | DBMET01437 | |
| 0.252 | 0.015 | 0.423 | Cystathionine beta-synthase inhibitor | 0.306 0.009 DBMET01436 0.423 0.004 DBMET01437 0.226 0.019 DB09157 0.231 0.018 DBMET03364 0.158 0.037 DBMET00507 | DBMET01437 | |
| 0.244 | 0.008 | 0.475 | NADH dehydrogenase inhibitor | 0.318 0.006 DBMET01436 0.475 0.003 DBMET01437 0.251 0.008 DB09157 0.211 0.01 DBMET03364 0.199 0.01 DBMET00507 | DBMET01437 | |
| 0.237 | 0.004 | 0.237 | HIV-1 integrase inhibitor | 0.096 0.027 DBMET01436 0.122 0.014 DBMET01437 0.096 0.027 DBMET00507 | ||
| 0.235 | 0.003 | 0.639 | Aconitate hydratase inhibitor | 0.306 0.002 DBMET01436 0.639 0.001 DBMET01437 0.155 0.004 DB09157 0.175 0.004 DBMET03364 0.179 0.004 DBMET00507 | DBMET01437 | |
| 0.254 | 0.03 | 0.364 | Nitric-oxide synthase stimulant | 0.286 0.015 DBMET01436 0.271 0.021 DBMET01437 0.294 0.013 DB09157 0.284 0.016 DBMET03364 0.364 0.004 DBMET00507 | DBMET00507 | |
| 0.229 | 0.007 | 0.413 | Creatine kinase inhibitor | 0.283 0.004 DBMET01436 0.413 0.003 DBMET01437 0.214 0.009 DB09157 0.238 0.006 DBMET03364 0.155 0.022 DBMET00507 | DBMET01437 | |
| 0.305 | 0.083 | 0.398 | Vasodilator, coronary | 0.369 0.047 DBMET01436 0.398 0.036 DBMET01437 0.278 0.107 DB09157 0.339 0.061 DBMET03364 0.309 0.08 DBMET00507 | DBMET01437 | |
| 0.234 | 0.016 | 0.32 | Mannose-6-phosphate isomerase inhibitor | 0.28 0.007 DBMET01436 0.32 0.005 DBMET01437 0.215 0.023 DB09157 0.223 0.02 DBMET03364 0.179 0.043 DBMET00507 | DBMET01437 | |
| 0.227 | 0.01 | 0.462 | Histidine decarboxylase inhibitor | 0.316 0.005 DBMET01436 0.462 0.003 DBMET01437 0.189 0.014 DB09157 0.182 0.015 DBMET03364 0.334 0.005 DBMET00507 | DBMET01437 | |
| 0.238 | 0.022 | 0.3 | 5 Hydroxytryptamine 3E antagonist | 0.262 0.012 DBMET01436 0.215 0.041 DBMET01437 0.274 0.008 DB09157 0.3 0.005 DBMET03364 0.18 0.105 DBMET00507 | DBMET03364 | |
| 0.221 | 0.01 | 0.221 | Beta glucuronidase inhibitor | 0.138 0.031 DBMET01436 0.15 0.025 DBMET01437 0.099 0.071 DB09157 0.11 0.056 DBMET03364 | ||
| 0.25 | 0.039 | 0.267 | Neurotrophic factor enhancer | 0.254 0.036 DBMET01436 0.259 0.034 DBMET01437 0.233 0.049 DB09157 0.267 0.03 DBMET03364 0.265 0.031 DBMET00507 | DBMET03364 | |
| 0.216 | 0.006 | 0.558 | Glutamate decarboxylase inhibitor | 0.266 0.004 DBMET01436 0.558 0.002 DBMET01437 0.178 0.009 DB09157 0.173 0.009 DBMET03364 0.265 0.004 DBMET00507 | DBMET01437 | |
| 0.304 | 0.095 | 0.5 | Vasodilator, peripheral | 0.425 0.048 DBMET01436 0.5 0.028 DBMET01437 0.27 0.113 DB09157 0.415 0.051 DBMET03364 0.224 0.149 DBMET00507 | DBMET01437 | |
| 0.211 | 0.011 | 0.332 | GABA C receptor antagonist | 0.267 0.005 DBMET01436 0.332 0.004 DBMET01437 0.257 0.006 DB09157 0.304 0.004 DBMET03364 0.276 0.005 DBMET00507 | DBMET01437 | |
| 0.207 | 0.007 | 0.405 | Electrolyte absorption antagonist | 0.266 0.004 DBMET01436 0.405 0.003 DBMET01437 0.174 0.012 DB09157 0.19 0.009 DBMET03364 0.223 0.006 DBMET00507 | DBMET01437 | |
| 0.208 | 0.009 | 0.492 | Glutamate dehydrogenase inhibitor | 0.268 0.006 DBMET01436 0.492 0.003 DBMET01437 0.19 0.011 DB09157 0.169 0.013 DBMET03364 0.228 0.008 DBMET00507 | DBMET01437 | |
| 0.202 | 0.008 | 0.304 | GABA C receptor rho-1 antagonist | 0.246 0.004 DBMET01436 0.304 0.003 DBMET01437 0.223 0.005 DB09157 0.262 0.004 DBMET03364 0.268 0.004 DBMET00507 | DBMET01437 | |
| 0.196 | 0.004 | 0.229 | Ca2+-transporting ATPase inhibitor | 0.208 0.003 DBMET01436 0.229 0.002 DBMET01437 0.192 0.004 DB09157 0.195 0.004 DBMET03364 0.156 0.031 DBMET00507 | DBMET01437 | |
| 0.196 | 0.007 | 0.431 | Phenylalanine 4-hydroxylase inhibitor | 0.27 0.004 DBMET01436 0.431 0.003 DBMET01437 0.156 0.011 DB09157 0.167 0.01 DBMET03364 0.253 0.005 DBMET00507 | DBMET01437 | |
| 0.229 | 0.041 | 0.356 | Lipocortins synthesis antagonist | 0.296 0.022 DBMET01436 0.356 0.013 DBMET01437 0.157 0.095 DBMET03364 0.15 0.105 DBMET00507 | DBMET01437 | |
| 0.21 | 0.024 | 0.232 | Arachidonic acid antagonist | 0.224 0.015 DBMET01436 0.232 0.011 DBMET01437 0.219 0.018 DB09157 0.224 0.015 DBMET03364 0.194 0.039 DBMET00507 | DBMET01437 | |
| 0.241 | 0.055 | 0.368 | RNA-directed DNA polymerase inhibitor | 0.293 0.033 DBMET01436 0.349 0.024 DBMET01437 0.299 0.032 DB09157 0.368 0.022 DBMET03364 0.176 0.14 DBMET00507 | DBMET03364 | |
| 0.2 | 0.019 | 0.378 | Carbonic anhydrase XV inhibitor | 0.269 0.01 DBMET01436 0.378 0.004 DBMET01437 0.15 0.031 DB09157 0.163 0.026 DBMET03364 0.109 0.056 DBMET00507 | DBMET01437 | |
| 0.201 | 0.027 | 0.419 | Aldehyde dehydrogenase inhibitor | 0.281 0.014 DBMET01436 0.419 0.005 DBMET01437 0.162 0.041 DB09157 0.178 0.034 DBMET03364 0.305 0.011 DBMET00507 | DBMET01437 | |
| 0.178 | 0.007 | 0.251 | Acyl-CoA dehydrogenase inhibitor | 0.209 0.005 DBMET01436 0.251 0.003 DBMET01437 0.192 0.006 DB09157 0.161 0.008 DBMET03364 0.14 0.01 DBMET00507 | DBMET01437 | |
| 0.209 | 0.038 | 0.295 | Interferon gamma antagonist | 0.212 0.037 DBMET01436 0.295 0.021 DBMET01437 0.186 0.047 DB09157 0.243 0.03 DBMET03364 0.138 0.095 DBMET00507 | DBMET01437 | |
| 0.193 | 0.023 | 0.276 | Aminopeptidase B inhibitor | 0.219 0.017 DBMET01436 0.276 0.01 DBMET01437 0.181 0.026 DB09157 0.186 0.025 DBMET03364 0.248 0.013 DBMET00507 | DBMET01437 | |
| 0.173 | 0.009 | 0.319 | Argininosuccinate synthase inhibitor | 0.218 0.007 DBMET01436 0.319 0.004 DBMET01437 0.171 0.01 DB09157 0.164 0.01 DBMET03364 0.131 0.014 DBMET00507 | DBMET01437 | |
| 0.187 | 0.024 | 0.24 | Cyclooxygenase 3 inhibitor | 0.217 0.014 DBMET01436 0.24 0.01 DBMET01437 0.157 0.042 DB09157 0.17 0.033 DBMET03364 0.158 0.042 DBMET00507 | DBMET01437 | |
| 0.171 | 0.013 | 0.249 | DOPA decarboxylase inhibitor | 0.197 0.007 DBMET01436 0.249 0.004 DBMET01437 0.177 0.011 DB09157 0.182 0.01 DBMET03364 0.14 0.027 DBMET00507 | DBMET01437 | |
| 0.197 | 0.04 | 0.238 | ATPase inhibitor | 0.212 0.028 DBMET01436 0.222 0.023 DBMET01437 0.18 0.058 DB09157 0.238 0.017 DBMET03364 0.2 0.037 DBMET00507 | DBMET03364 | |
| 0.259 | 0.105 | 0.597 | Caspase 3 stimulant | 0.597 0.01 DBMET01436 0.207 0.159 DBMET03364 | DBMET01436 | |
| 0.168 | 0.015 | 0.29 | Phosphofructokinase-1 inhibitor | 0.203 0.011 DBMET01436 0.29 0.006 DBMET01437 0.218 0.009 DB09157 0.198 0.011 DBMET03364 0.135 0.021 DBMET00507 | DBMET01437 | |
| 0.18 | 0.029 | 0.226 | Cathepsin H inhibitor | 0.209 0.02 DBMET01436 0.226 0.017 DBMET01437 0.168 0.035 DB09157 0.194 0.024 DBMET03364 0.154 0.043 DBMET00507 | DBMET01437 | |
| 0.176 | 0.027 | 0.231 | Sphingosine 1-phosphate receptor 5 antagonist | 0.199 0.012 DBMET01436 0.231 0.005 DBMET01437 0.169 0.034 DB09157 0.18 0.024 DBMET03364 0.154 0.055 DBMET00507 | DBMET01437 | |
| 0.196 | 0.047 | 0.397 | Phospholipase C inhibitor | 0.242 0.027 DBMET01436 0.397 0.011 DBMET01437 0.193 0.049 DB09157 0.214 0.036 DBMET03364 0.355 0.014 DBMET00507 | DBMET01437 | |
| 0.168 | 0.019 | 0.221 | Heat shock protein 70 antagonist | 0.19 0.008 DBMET01436 0.221 0.005 DBMET01437 0.157 0.033 DB09157 0.184 0.01 DBMET03364 0.146 0.055 DBMET00507 | DBMET01437 | |
| 0.237 | 0.089 | 0.288 | 5 Hydroxytryptamine 1E antagonist | 0.275 0.049 DBMET01436 0.216 0.113 DBMET01437 0.257 0.067 DB09157 0.288 0.038 DBMET03364 | DBMET03364 | |
| 0.194 | 0.046 | 0.316 | Amylase inhibitor | 0.253 0.027 DBMET01436 0.316 0.016 DBMET01437 0.188 0.048 DB09157 0.205 0.042 DBMET03364 0.194 0.046 DBMET00507 | DBMET01437 | |
| 0.168 | 0.021 | 0.227 | TRPA1 agonist | 0.207 0.009 DBMET01436 0.227 0.007 DBMET01437 0.131 0.047 DB09157 0.157 0.026 DBMET03364 0.153 0.029 DBMET00507 | DBMET01437 | |
| 0.206 | 0.06 | 0.434 | Sigma receptor agonist | 0.434 0.017 DBMET01436 0.413 0.02 DBMET01437 0.167 0.075 DBMET03364 | DBMET01436 | |
| 0.164 | 0.02 | 0.261 | HIV-1 integrase (Overall Integration) inhibitor | 0.208 0.01 DBMET01436 0.261 0.004 DBMET01437 0.158 0.023 DB09157 0.194 0.013 DBMET03364 0.234 0.006 DBMET00507 | DBMET01437 | |
| 0.177 | 0.036 | 0.234 | Toll-Like receptor 2 antagonist | 0.206 0.021 DBMET01436 0.207 0.021 DBMET01437 0.158 0.047 DB09157 0.171 0.039 DBMET03364 0.234 0.012 DBMET00507 | DBMET00507 | |
| 0.146 | 0.006 | 0.168 | Granulocyte macrophage colony stimulating factor agonist | 0.168 0.004 DBMET01436 0.155 0.005 DBMET01437 0.141 0.007 DB09157 0.161 0.004 DBMET03364 0.132 0.01 DBMET00507 | DBMET01436 | |
| 0.185 | 0.045 | 0.345 | Hexokinase inhibitor | 0.23 0.022 DBMET01436 0.345 0.007 DBMET01437 0.162 0.066 DB09157 0.187 0.044 DBMET03364 0.162 0.066 DBMET00507 | DBMET01437 | |
| 0.146 | 0.009 | 0.421 | GABA aminotransferase inhibitor | 0.187 0.005 DBMET01436 0.421 0.003 DBMET01437 0.11 0.021 DB09157 0.161 0.006 DBMET03364 0.134 0.011 DBMET00507 | DBMET01437 | |
| 0.16 | 0.024 | 0.277 | Catalase inhibitor | 0.202 0.015 DBMET01436 0.277 0.007 DBMET01437 0.167 0.022 DB09157 0.166 0.023 DBMET03364 0.217 0.012 DBMET00507 | DBMET01437 | |
| 0.161 | 0.025 | 0.322 | Carbonic anhydrase III inhibitor | 0.221 0.013 DBMET01436 0.322 0.005 DBMET01437 0.129 0.039 DB09157 0.158 0.026 DBMET03364 0.133 0.036 DBMET00507 | DBMET01437 | |
| 0.148 | 0.013 | 0.23 | Aminopeptidase I inhibitor | 0.173 0.009 DBMET01436 0.23 0.005 DBMET01437 0.14 0.014 DB09157 0.142 0.014 DBMET03364 0.201 0.007 DBMET00507 | DBMET01437 | |
| 0.257 | 0.123 | 0.379 | Transcription factor NF kappa B inhibitor | 0.297 0.096 DBMET01436 0.379 0.068 DBMET01437 0.188 0.181 DB09157 0.296 0.096 DBMET03364 0.251 0.127 DBMET00507 | DBMET01437 | |
| 0.14 | 0.008 | 0.21 | Purinergic P2X1 antagonist | 0.165 0.005 DBMET01436 0.21 0.003 DBMET01437 0.123 0.011 DB09157 0.12 0.012 DBMET03364 0.087 0.021 DBMET00507 | DBMET01437 | |
| 0.167 | 0.039 | 0.202 | Adenylate cyclase stimulant | 0.186 0.021 DBMET01436 0.186 0.022 DBMET01437 0.195 0.016 DB09157 0.202 0.013 DBMET03364 0.184 0.023 DBMET00507 | DBMET03364 | |
| 0.149 | 0.022 | 0.23 | Prolactin inhibitor | 0.184 0.012 DBMET01436 0.171 0.015 DBMET01437 0.163 0.017 DB09157 0.23 0.005 DBMET03364 0.125 0.035 DBMET00507 | DBMET03364 | |
| 0.156 | 0.035 | 0.192 | Microtubule formation inhibitor | 0.192 0.022 DBMET01436 0.189 0.022 DBMET01437 0.144 0.041 DB09157 0.186 0.023 DBMET03364 0.152 0.037 DBMET00507 | DBMET01436 | |
| 0.143 | 0.022 | 0.163 | Anabolic | 0.156 0.015 DBMET01436 0.162 0.013 DBMET01437 0.147 0.019 DB09157 0.163 0.012 DBMET03364 0.126 0.034 DBMET00507 | DBMET03364 | |
| 0.151 | 0.03 | 0.209 | Photosensitizer | 0.186 0.016 DBMET01436 0.209 0.011 DBMET01437 0.155 0.028 DB09157 0.172 0.02 DBMET03364 0.147 0.033 DBMET00507 | DBMET01437 | |
| 0.162 | 0.042 | 0.174 | Nav1.6 sodium channel blocker | 0.174 0.032 DBMET01436 0.136 0.072 DBMET01437 0.142 0.063 DB09157 0.173 0.033 DBMET03364 | DBMET01436 | |
| 0.128 | 0.01 | 0.195 | D-Ala-D-Ala ligase inhibitor | 0.148 0.005 DBMET01436 0.195 0.003 DBMET01437 0.115 0.016 DB09157 0.111 0.019 DBMET03364 0.111 0.019 DBMET00507 | DBMET01437 | |
| 0.123 | 0.005 | 0.238 | Glutamate (mGluR6) antagonist | 0.146 0.004 DBMET01436 0.238 0.002 DBMET01437 0.114 0.007 DB09157 0.12 0.005 DBMET03364 0.09 0.015 DBMET00507 | DBMET01437 | |
| 0.15 | 0.033 | 0.2 | Sphingosine 1-phosphate receptor 4 antagonist | 0.181 0.014 DBMET01436 0.2 0.009 DBMET01437 0.138 0.045 DB09157 0.149 0.034 DBMET03364 0.13 0.056 DBMET00507 | DBMET01437 | |
| 0.153 | 0.037 | 0.198 | Sphingosine 1-phosphate receptor 2 antagonist | 0.177 0.017 DBMET01436 0.198 0.008 DBMET01437 0.155 0.034 DB09157 0.164 0.026 DBMET03364 0.153 0.037 DBMET00507 | DBMET01437 | |
| 0.129 | 0.012 | 0.129 | T cell inhibitor | 0.113 0.016 DBMET00507 | ||
| 0.149 | 0.033 | 0.264 | Mucolytic | 0.213 0.011 DBMET01436 0.237 0.008 DBMET01437 0.145 0.036 DB09157 0.154 0.03 DBMET03364 0.264 0.005 DBMET00507 | DBMET00507 | |
| 0.216 | 0.103 | 0.236 | DNA damaging | 0.233 0.091 DBMET01436 0.226 0.095 DBMET01437 0.236 0.089 DBMET03364 0.231 0.092 DBMET00507 | DBMET03364 | |
| 0.127 | 0.018 | 0.165 | Glutamate release inhibitor | 0.161 0.008 DBMET01436 0.165 0.007 DBMET01437 0.137 0.014 DB09157 0.156 0.009 DBMET03364 0.092 0.057 DBMET00507 | DBMET01437 | |
| 0.168 | 0.061 | 0.21 | Melanin inhibitor | 0.197 0.042 DBMET01436 0.21 0.037 DBMET01437 0.164 0.065 DB09157 0.177 0.054 DBMET03364 0.161 0.068 DBMET00507 | DBMET01437 | |
| 0.154 | 0.047 | 0.224 | Anesthetic local | 0.224 0.026 DBMET01436 0.202 0.032 DBMET01437 0.094 0.088 DB09157 0.136 0.056 DBMET03364 0.094 0.089 DBMET00507 | DBMET01436 | |
| 0.122 | 0.015 | 0.212 | Carbamoyl phosphate synthetase inhibitor | 0.15 0.011 DBMET01436 0.169 0.009 DBMET01437 0.212 0.007 DB09157 0.178 0.009 DBMET03364 0.127 0.014 DBMET00507 | DB09157 | |
| 0.162 | 0.056 | 0.201 | CF transmembrane conductance regulator agonist | 0.192 0.027 DBMET01436 0.185 0.032 DBMET01437 0.188 0.029 DB09157 0.201 0.021 DBMET03364 0.171 0.046 DBMET00507 | DBMET03364 | |
| 0.122 | 0.017 | 0.146 | Glycine receptor antagonist | 0.144 0.009 DBMET01436 0.146 0.008 DBMET01437 0.128 0.014 DB09157 0.139 0.01 DBMET03364 0.118 0.019 DBMET00507 | DBMET01437 | |
| 0.169 | 0.064 | 0.211 | Neurotensin receptor agonist | 0.192 0.039 DBMET01436 0.207 0.031 DBMET01437 0.179 0.05 DB09157 0.211 0.03 DBMET03364 0.205 0.032 DBMET00507 | DBMET03364 | |
| 0.132 | 0.028 | 0.367 | Alcohol dehydrogenase inhibitor | 0.193 0.013 DBMET01436 0.367 0.004 DBMET01437 0.108 0.044 DB09157 0.114 0.039 DBMET03364 0.209 0.011 DBMET00507 | DBMET01437 | |
| 0.11 | 0.006 | 0.132 | Glutamate (mGluR7) antagonist | 0.126 0.004 DBMET01436 0.132 0.004 DBMET01437 0.112 0.006 DB09157 0.118 0.005 DBMET03364 0.073 0.038 DBMET00507 | DBMET01437 | |
| 0.127 | 0.024 | 0.152 | Glutamate (mGluR7) agonist | 0.152 0.011 DBMET01436 0.137 0.018 DBMET01437 0.131 0.021 DB09157 0.151 0.012 DBMET03364 0.142 0.015 DBMET00507 | DBMET01436 | |
| 0.125 | 0.022 | 0.214 | Ornithine decarboxylase inhibitor | 0.146 0.012 DBMET01436 0.214 0.004 DBMET01437 0.104 0.04 DB09157 0.113 0.031 DBMET03364 0.127 0.021 DBMET00507 | DBMET01437 | |
| 0.148 | 0.045 | 0.269 | Cholesterol synthesis inhibitor | 0.187 0.03 DBMET01436 0.269 0.015 DBMET01437 0.14 0.05 DB09157 0.188 0.03 DBMET03364 0.154 0.042 DBMET00507 | DBMET01437 | |
| 0.198 | 0.095 | 0.343 | Cyclic AMP phosphodiesterase inhibitor | 0.287 0.047 DBMET01436 0.343 0.027 DBMET01437 0.202 0.092 DB09157 0.307 0.039 DBMET03364 | DBMET01437 | |
| 0.127 | 0.025 | 0.159 | Histamine N-methyltransferase inhibitor | 0.151 0.014 DBMET01436 0.159 0.011 DBMET01437 0.123 0.028 DB09157 0.151 0.014 DBMET03364 | DBMET01437 | |
| 0.235 | 0.138 | 0.474 | Antithrombotic | 0.305 0.085 DBMET01436 0.43 0.042 DBMET01437 0.215 0.159 DB09157 0.292 0.094 DBMET03364 0.474 0.033 DBMET00507 | DBMET00507 | |
| 0.186 | 0.089 | 0.278 | Insulin sensitizer | 0.224 0.052 DBMET01436 0.278 0.022 DBMET01437 0.173 0.104 DB09157 0.201 0.073 DBMET03364 0.267 0.026 DBMET00507 | DBMET01437 | |
| 0.121 | 0.025 | 0.201 | Macrophage migration inhibitory factor inhibitor | 0.137 0.019 DBMET01436 0.201 0.008 DBMET01437 0.07 0.066 DB09157 0.115 0.027 DBMET03364 | DBMET01437 | |
| 0.186 | 0.09 | 0.333 | Pyruvate kinase inhibitor | 0.287 0.051 DBMET01436 0.333 0.039 DBMET01437 0.138 0.126 DB09157 0.209 0.076 DBMET03364 | DBMET01437 | |
| 0.111 | 0.015 | 0.208 | Glycine receptor agonist | 0.141 0.008 DBMET01436 0.208 0.004 DBMET01437 0.128 0.011 DB09157 0.14 0.008 DBMET03364 0.112 0.015 DBMET00507 | DBMET01437 | |
| 0.205 | 0.11 | 0.249 | Neuropeptide Y2 antagonist | 0.245 0.061 DBMET01436 0.233 0.073 DBMET01437 0.21 0.103 DB09157 0.249 0.057 DBMET03364 0.209 0.104 DBMET00507 | DBMET03364 | |
| 0.149 | 0.055 | 0.246 | NADPH oxidase inhibitor | 0.181 0.04 DBMET01436 0.246 0.022 DBMET01437 0.126 0.075 DBMET03364 0.127 0.074 DBMET00507 | DBMET01437 | |
| 0.123 | 0.028 | 0.28 | Carbonic anhydrase VI inhibitor | 0.18 0.016 DBMET01436 0.28 0.007 DBMET01437 0.095 0.042 DB09157 0.119 0.03 DBMET03364 0.116 0.031 DBMET00507 | DBMET01437 | |
| 0.129 | 0.035 | 0.163 | Acetylcholine release stimulant | 0.154 0.014 DBMET01436 0.133 0.03 DBMET01437 0.139 0.024 DB09157 0.163 0.01 DBMET03364 0.1 0.088 DBMET00507 | DBMET03364 | |
| 0.118 | 0.024 | 0.186 | Glutathione S-transferase inhibitor | 0.159 0.01 DBMET01436 0.145 0.013 DBMET01437 0.088 0.05 DB09157 0.092 0.045 DBMET03364 0.186 0.007 DBMET00507 | DBMET00507 | |
| 0.109 | 0.016 | 0.169 | Estrogen-related receptor beta agonist | 0.123 0.009 DBMET01436 0.124 0.009 DBMET01437 0.114 0.013 DB09157 0.119 0.01 DBMET03364 0.169 0.003 DBMET00507 | DBMET00507 | |
| 0.103 | 0.014 | 0.163 | GABA B receptor agonist | 0.125 0.006 DBMET01436 0.163 0.004 DBMET01437 0.101 0.016 DB09157 0.104 0.014 DBMET03364 0.111 0.01 DBMET00507 | DBMET01437 | |
| 0.12 | 0.031 | 0.144 | Lanosterol 14 alpha demethylase inhibitor | 0.144 0.014 DBMET01436 0.136 0.018 DBMET01437 0.131 0.021 DB09157 0.14 0.015 DBMET03364 0.133 0.02 DBMET00507 | DBMET01436 | |
| 0.153 | 0.066 | 0.24 | Protein kinase stimulant | 0.203 0.04 DBMET01436 0.24 0.029 DBMET01437 0.151 0.068 DB09157 0.213 0.037 DBMET03364 0.128 0.085 DBMET00507 | DBMET01437 | |
| 0.133 | 0.046 | 0.245 | 5 Hydroxytryptamine 3A agonist | 0.175 0.024 DBMET01436 0.113 0.062 DBMET01437 0.205 0.014 DB09157 0.245 0.006 DBMET03364 | DBMET03364 | |
| 0.101 | 0.016 | 0.159 | NMDA receptor glycine site agonist | 0.124 0.008 DBMET01436 0.159 0.004 DBMET01437 0.092 0.021 DB09157 0.113 0.011 DBMET03364 0.129 0.007 DBMET00507 | DBMET01437 | |
| 0.096 | 0.011 | 0.137 | Exportin-1 inhibitor | 0.115 0.005 DBMET01436 0.091 0.014 DBMET01437 0.113 0.005 DB09157 0.137 0.004 DBMET03364 0.069 0.045 DBMET00507 | DBMET03364 | |
| 0.095 | 0.01 | 0.134 | Potassium channel intermediate-conductance Ca-activated blocker | 0.134 0.005 DBMET01436 0.11 0.007 DBMET01437 0.075 0.022 DB09157 0.096 0.01 DBMET03364 | DBMET01436 | |
| 0.087 | 0.003 | 0.189 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.105 0.003 DBMET01436 0.189 0.001 DBMET01437 0.072 0.004 DB09157 0.065 0.005 DBMET03364 0.048 0.018 DBMET00507 | DBMET01437 | |
| 0.149 | 0.066 | 0.27 | Cell wall synthesis inhibitor | 0.242 0.018 DBMET01436 0.27 0.013 DBMET01437 0.165 0.051 DB09157 0.252 0.015 DBMET03364 0.191 0.034 DBMET00507 | DBMET01437 | |
| 0.116 | 0.033 | 0.22 | ABCA1 expression enhancer | 0.107 0.042 DBMET01436 0.22 0.008 DBMET01437 | DBMET01437 | |
| 0.097 | 0.015 | 0.116 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.11 0.009 DBMET01436 0.105 0.01 DBMET01437 0.106 0.01 DB09157 0.116 0.007 DBMET03364 0.09 0.022 DBMET00507 | DBMET03364 | |
| 0.098 | 0.016 | 0.163 | Phospholipase D inhibitor | 0.117 0.007 DBMET01436 0.119 0.007 DBMET01437 0.108 0.011 DB09157 0.122 0.006 DBMET03364 0.163 0.002 DBMET00507 | DBMET00507 | |
| 0.189 | 0.108 | 0.281 | Aryl hydrocarbon receptor agonist | 0.281 0.067 DBMET01436 0.264 0.073 DBMET01437 0.161 0.127 DB09157 0.184 0.111 DBMET03364 | DBMET01436 | |
| 0.097 | 0.017 | 0.219 | Ornithine carbamoyltransferase inhibitor | 0.124 0.012 DBMET01436 0.219 0.006 DBMET01437 0.11 0.014 DB09157 0.091 0.018 DBMET03364 0.128 0.012 DBMET00507 | DBMET01437 | |
| 0.112 | 0.032 | 0.185 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.147 0.02 DBMET01436 0.185 0.011 DBMET01437 0.089 0.044 DB09157 0.103 0.036 DBMET03364 0.077 0.054 DBMET00507 | DBMET01437 | |
| 0.126 | 0.047 | 0.251 | Expectorant | 0.213 0.018 DBMET01436 0.25 0.013 DBMET01437 0.116 0.054 DB09157 0.132 0.043 DBMET03364 0.251 0.013 DBMET00507 | DBMET00507 | |
| 0.094 | 0.016 | 0.156 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.118 0.011 DBMET01436 0.128 0.01 DBMET01437 0.156 0.008 DB09157 0.137 0.009 DBMET03364 0.077 0.022 DBMET00507 | DB09157 | |
| 0.084 | 0.009 | 0.138 | Dihydroorotate oxidase inhibitor | 0.101 0.005 DBMET01436 0.138 0.003 DBMET01437 0.08 0.01 DB09157 0.089 0.007 DBMET03364 0.054 0.041 DBMET00507 | DBMET01437 | |
| 0.083 | 0.008 | 0.117 | Glucose-6-phosphate isomerase inhibitor | 0.096 0.005 DBMET01436 0.105 0.004 DBMET01437 0.117 0.004 DB09157 0.104 0.004 DBMET03364 0.074 0.01 DBMET00507 | DB09157 | |
| 0.184 | 0.11 | 0.367 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.304 0.063 DBMET01436 0.367 0.046 DBMET01437 0.161 0.13 DB09157 0.195 0.103 DBMET03364 0.189 0.107 DBMET00507 | DBMET01437 | |
| 0.095 | 0.021 | 0.218 | NMDA receptor agonist | 0.13 0.011 DBMET01436 0.218 0.004 DBMET01437 0.087 0.025 DB09157 0.118 0.014 DBMET03364 0.165 0.006 DBMET00507 | DBMET01437 | |
| 0.134 | 0.06 | 0.167 | Vanilloid 1 agonist | 0.152 0.036 DBMET01436 0.148 0.041 DBMET01437 0.137 0.054 DB09157 0.165 0.026 DBMET03364 0.167 0.025 DBMET00507 | DBMET00507 | |
| 0.106 | 0.033 | 0.185 | CYP2A6 inhibitor | 0.147 0.017 DBMET01436 0.089 0.042 DBMET01437 0.124 0.025 DB09157 0.185 0.009 DBMET03364 | DBMET03364 | |
| 0.111 | 0.038 | 0.111 | Protein kinase A inhibitor | |||
| 0.116 | 0.044 | 0.116 | Falcipain 2 inhibitor | |||
| 0.116 | 0.046 | 0.116 | Falcipain inhibitor | |||
| 0.078 | 0.008 | 0.099 | Pregnane X receptor antagonist | 0.089 0.004 DBMET01436 0.099 0.004 DBMET01437 0.078 0.007 DB09157 0.081 0.006 DBMET03364 | DBMET01437 | |
| 0.11 | 0.041 | 0.151 | Calcium antagonist | 0.151 0.022 DBMET01436 0.13 0.03 DBMET01437 0.101 0.047 DB09157 0.122 0.034 DBMET03364 | DBMET01436 | |
| 0.147 | 0.078 | 0.252 | Cytidine deaminase inhibitor | 0.223 0.038 DBMET01436 0.252 0.029 DBMET01437 0.132 0.089 DB09157 0.225 0.037 DBMET03364 | DBMET01437 | |
| 0.106 | 0.038 | 0.151 | Bile acid receptor antagonist | 0.12 0.02 DBMET01436 0.151 0.007 DBMET01437 0.098 0.053 DB09157 0.103 0.043 DBMET03364 0.119 0.021 DBMET00507 | DBMET01437 | |
| 0.103 | 0.037 | 0.24 | Carbonic anhydrase XIII inhibitor | 0.153 0.021 DBMET01436 0.24 0.009 DBMET01437 0.084 0.047 DB09157 0.131 0.026 DBMET03364 0.076 0.053 DBMET00507 | DBMET01437 | |
| 0.119 | 0.054 | 0.176 | Falcipain 3 inhibitor | 0.159 0.032 DBMET01436 0.174 0.027 DBMET01437 0.148 0.038 DB09157 0.163 0.031 DBMET03364 0.176 0.026 DBMET00507 | DBMET00507 | |
| 0.09 | 0.025 | 0.111 | MAP kinase kinase 7 inhibitor | 0.1 0.013 DBMET01436 0.111 0.006 DBMET01437 0.095 0.017 DB09157 0.109 0.007 DBMET03364 0.09 0.024 DBMET00507 | DBMET01437 | |
| 0.069 | 0.005 | 0.12 | Glutamate (mGluR8) agonist | 0.084 0.004 DBMET01436 0.12 0.002 DBMET01437 0.073 0.005 DB09157 0.07 0.005 DBMET03364 0.05 0.012 DBMET00507 | DBMET01437 | |
| 0.129 | 0.065 | 0.149 | Nav1.3 sodium channel blocker | 0.149 0.049 DBMET01436 0.122 0.072 DBMET01437 0.137 0.057 DBMET03364 0.119 0.075 DBMET00507 | DBMET01436 | |
| 0.072 | 0.008 | 0.24 | Fumarate hydratase inhibitor | 0.097 0.005 DBMET01436 0.24 0.003 DBMET01437 0.094 0.006 DB09157 0.079 0.007 DBMET03364 0.062 0.01 DBMET00507 | DBMET01437 | |
| 0.145 | 0.083 | 0.275 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.193 0.023 DBMET01436 0.275 0.005 DBMET01437 | DBMET01437 | |
| 0.072 | 0.01 | 0.181 | Glutamate (mGluR4) antagonist | 0.108 0.005 DBMET01436 0.181 0.003 DBMET01437 0.053 0.018 DB09157 0.061 0.013 DBMET03364 0.055 0.016 DBMET00507 | DBMET01437 | |
| 0.068 | 0.007 | 0.24 | Retinoic acid alpha receptor agonist | 0.1 0.004 DBMET01436 0.24 0.002 DBMET01437 | DBMET01437 | |
| 0.067 | 0.006 | 0.078 | Guanylate cyclase inhibitor | 0.073 0.004 DBMET01436 0.078 0.003 DBMET01437 0.068 0.005 DB09157 0.071 0.005 DBMET03364 0.04 0.034 DBMET00507 | DBMET01437 | |
| 0.109 | 0.048 | 0.285 | Potassium channel (Ca-activated) activator | 0.173 0.021 DBMET01436 0.285 0.005 DBMET01437 0.127 0.037 DBMET03364 0.164 0.024 DBMET00507 | DBMET01437 | |
| 0.143 | 0.083 | 0.292 | Phospholipase A2 inhibitor | 0.209 0.038 DBMET01436 0.292 0.015 DBMET01437 0.14 0.086 DBMET03364 0.208 0.038 DBMET00507 | DBMET01437 | |
| 0.088 | 0.028 | 0.113 | Vanilloid 4 agonist | 0.102 0.015 DBMET01436 0.091 0.025 DBMET01437 0.109 0.011 DB09157 0.113 0.009 DBMET03364 0.092 0.024 DBMET00507 | DBMET03364 | |
| 0.069 | 0.009 | 0.155 | Retinoid X alpha receptor agonist | 0.097 0.005 DBMET01436 0.155 0.003 DBMET01437 0.04 0.019 DB09157 0.05 0.014 DBMET03364 0.037 0.022 DBMET00507 | DBMET01437 | |
| 0.226 | 0.167 | 0.347 | Calpain 2 inhibitor | 0.336 0.094 DBMET01436 0.309 0.108 DBMET01437 0.21 0.179 DB09157 0.347 0.088 DBMET03364 0.322 0.101 DBMET00507 | DBMET03364 | |
| 0.073 | 0.015 | 0.111 | Alpha-mannosidase inhibitor | 0.087 0.009 DBMET01436 0.095 0.007 DBMET01437 0.083 0.01 DB09157 0.084 0.01 DBMET03364 0.111 0.005 DBMET00507 | DBMET00507 | |
| 0.08 | 0.023 | 0.173 | Carbonic anhydrase VB inhibitor | 0.122 0.012 DBMET01436 0.173 0.007 DBMET01437 0.073 0.026 DB09157 0.118 0.013 DBMET03364 0.058 0.037 DBMET00507 | DBMET01437 | |
| 0.064 | 0.007 | 0.093 | Nerve growth factor antagonist | 0.077 0.004 DBMET01436 0.093 0.003 DBMET01437 0.06 0.01 DB09157 0.068 0.006 DBMET03364 | DBMET01437 | |
| 0.155 | 0.099 | 0.325 | DNA methyltransferase I inhibitor | 0.239 0.052 DBMET01436 0.325 0.019 DBMET01437 0.139 0.117 DB09157 0.208 0.065 DBMET03364 0.268 0.039 DBMET00507 | DBMET01437 | |
| 0.195 | 0.14 | 0.336 | Transcription factor STAT3 inhibitor | 0.271 0.069 DBMET01436 0.336 0.038 DBMET01437 0.184 0.158 DB09157 0.262 0.074 DBMET03364 0.233 0.098 DBMET00507 | DBMET01437 | |
| 0.129 | 0.074 | 0.154 | Nav1.2 sodium channel blocker | 0.154 0.055 DBMET01436 0.117 0.087 DBMET01437 0.144 0.061 DBMET03364 0.147 0.059 DBMET00507 | DBMET01436 | |
| 0.061 | 0.006 | 0.092 | Kainate receptor agonist | 0.073 0.004 DBMET01436 0.092 0.003 DBMET01437 0.067 0.005 DB09157 0.067 0.005 DBMET03364 0.057 0.008 DBMET00507 | DBMET01437 | |
| 0.069 | 0.014 | 0.089 | Squalene epoxidase inhibitor | 0.089 0.007 DBMET01436 0.081 0.009 DBMET01437 0.063 0.018 DB09157 0.073 0.012 DBMET03364 | DBMET01436 | |
| 0.069 | 0.015 | 0.107 | Lysophosphatidic acid 3 receptor antagonist | 0.082 0.009 DBMET01436 0.107 0.004 DBMET01437 0.069 0.015 DB09157 0.07 0.014 DBMET03364 0.066 0.018 DBMET00507 | DBMET01437 | |
| 0.063 | 0.009 | 0.123 | GABA uptake inhibitor | 0.082 0.005 DBMET01436 0.123 0.003 DBMET01437 0.057 0.011 DB09157 0.075 0.006 DBMET03364 0.038 0.03 DBMET00507 | DBMET01437 | |
| 0.065 | 0.011 | 0.176 | Glutamate (mGluR group III) antagonist | 0.102 0.005 DBMET01436 0.176 0.003 DBMET01437 0.05 0.021 DB09157 0.058 0.014 DBMET03364 0.045 0.027 DBMET00507 | DBMET01437 | |
| 0.112 | 0.06 | 0.203 | Protein kinase C gamma inhibitor | 0.155 0.029 DBMET01436 0.203 0.013 DBMET01437 0.102 0.074 DB09157 0.122 0.051 DBMET03364 0.095 0.087 DBMET00507 | DBMET01437 | |
| 0.06 | 0.008 | 0.252 | Glutamate (mGluR3) antagonist | 0.091 0.005 DBMET01436 0.252 0.003 DBMET01437 0.048 0.014 DB09157 0.058 0.009 DBMET03364 0.038 0.024 DBMET00507 | DBMET01437 | |
| 0.125 | 0.074 | 0.186 | Antibacterial (Helicobacter pylori) | 0.186 0.026 DBMET01436 0.147 0.048 DBMET01437 0.116 0.087 DBMET03364 0.111 0.095 DBMET00507 | DBMET01436 | |
| 0.12 | 0.068 | 0.169 | Alkylator | 0.13 0.059 DBMET01436 0.145 0.049 DBMET01437 0.108 0.08 DB09157 0.133 0.057 DBMET03364 0.169 0.037 DBMET00507 | DBMET00507 | |
| 0.062 | 0.011 | 0.114 | Dopamine D5 agonist | 0.079 0.006 DBMET01436 0.072 0.008 DBMET01437 0.078 0.006 DB09157 0.114 0.004 DBMET03364 0.044 0.023 DBMET00507 | DBMET03364 | |
| 0.064 | 0.012 | 0.131 | Retinoid X receptor agonist | 0.084 0.007 DBMET01436 0.131 0.003 DBMET01437 0.038 0.024 DB09157 0.05 0.018 DBMET03364 0.033 0.027 DBMET00507 | DBMET01437 | |
| 0.167 | 0.117 | 0.236 | Histone acetyltransferase inhibitor | 0.215 0.049 DBMET01436 0.236 0.032 DBMET01437 0.161 0.125 DB09157 0.198 0.072 DBMET03364 0.188 0.088 DBMET00507 | DBMET01437 | |
| 0.069 | 0.019 | 0.09 | Ryanodine receptor antagonist | 0.082 0.008 DBMET01436 0.09 0.005 DBMET01437 0.075 0.012 DB09157 0.078 0.01 DBMET03364 0.065 0.025 DBMET00507 | DBMET01437 | |
| 0.076 | 0.026 | 0.109 | MDM2 inhibitor | 0.092 0.01 DBMET01436 0.109 0.005 DBMET01437 0.076 0.026 DB09157 0.081 0.019 DBMET03364 0.072 0.033 DBMET00507 | DBMET01437 | |
| 0.064 | 0.014 | 0.179 | Dihydroorotase inhibitor | 0.087 0.007 DBMET01436 0.179 0.003 DBMET01437 0.049 0.026 DB09157 0.055 0.02 DBMET03364 0.052 0.022 DBMET00507 | DBMET01437 | |
| 0.064 | 0.014 | 0.11 | Mannosidase inhibitor | 0.08 0.009 DBMET01436 0.11 0.005 DBMET01437 0.072 0.011 DB09157 0.074 0.01 DBMET03364 0.1 0.006 DBMET00507 | DBMET01437 | |
| 0.09 | 0.04 | 0.127 | Nicotinic alpha4beta2 receptor antagonist | 0.115 0.02 DBMET01436 0.083 0.047 DBMET01437 0.089 0.041 DB09157 0.127 0.014 DBMET03364 | DBMET03364 | |
| 0.078 | 0.029 | 0.093 | Protease 3C (Human rhinovirus) inhibitor | 0.093 0.019 DBMET01436 0.083 0.025 DBMET01437 0.082 0.026 DB09157 0.087 0.022 DBMET03364 0.085 0.023 DBMET00507 | DBMET01436 | |
| 0.076 | 0.027 | 0.176 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.106 0.015 DBMET01436 0.176 0.005 DBMET01437 0.054 0.047 DB09157 0.06 0.039 DBMET03364 0.06 0.04 DBMET00507 | DBMET01437 | |
| 0.07 | 0.021 | 0.127 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.091 0.012 DBMET01436 0.127 0.007 DBMET01437 0.077 0.018 DB09157 0.086 0.014 DBMET03364 | DBMET01437 | |
| 0.087 | 0.039 | 0.151 | Cathepsin G inhibitor | 0.125 0.026 DBMET01436 0.151 0.021 DBMET01437 0.072 0.051 DB09157 0.103 0.032 DBMET03364 0.147 0.022 DBMET00507 | DBMET01437 | |
| 0.135 | 0.087 | 0.195 | Thiol protease inhibitor | 0.174 0.052 DBMET01436 0.195 0.041 DBMET01437 0.13 0.097 DB09157 0.172 0.053 DBMET03364 0.185 0.046 DBMET00507 | DBMET01437 | |
| 0.083 | 0.035 | 0.151 | Carbonic anhydrase VA inhibitor | 0.117 0.019 DBMET01436 0.151 0.011 DBMET01437 0.076 0.04 DB09157 0.108 0.022 DBMET03364 0.084 0.034 DBMET00507 | DBMET01437 | |
| 0.064 | 0.017 | 0.076 | Immunoglobulin Fc receptor antagonist | 0.073 0.009 DBMET01436 0.073 0.009 DBMET01437 0.069 0.012 DB09157 0.076 0.008 DBMET03364 0.054 0.043 DBMET00507 | DBMET03364 | |
| 0.103 | 0.057 | 0.26 | Xanthine oxidase inhibitor | 0.196 0.02 DBMET01436 0.26 0.011 DBMET01437 0.084 0.083 DB09157 0.087 0.077 DBMET00507 | DBMET01437 | |
| 0.18 | 0.135 | 0.251 | Calpain inhibitor | 0.238 0.077 DBMET01436 0.227 0.088 DBMET01437 0.188 0.125 DB09157 0.246 0.068 DBMET03364 0.251 0.064 DBMET00507 | DBMET00507 | |
| 0.06 | 0.015 | 0.076 | Dopamine beta hydroxylase inhibitor | 0.072 0.007 DBMET01436 0.076 0.006 DBMET01437 0.063 0.012 DB09157 0.072 0.007 DBMET03364 | DBMET01437 | |
| 0.053 | 0.01 | 0.082 | Retinoid X receptor antagonist | 0.062 0.005 DBMET01436 0.082 0.003 DBMET01437 0.043 0.019 DB09157 0.053 0.01 DBMET03364 | DBMET01437 | |
| 0.064 | 0.022 | 0.087 | Nicotinic alpha3beta2 receptor antagonist | 0.087 0.01 DBMET01436 0.066 0.021 DBMET01437 0.063 0.023 DB09157 0.087 0.01 DBMET03364 | DBMET03364 | |
| 0.06 | 0.018 | 0.097 | Adenylate cyclase 1 inhibitor | 0.082 0.007 DBMET01436 0.066 0.014 DBMET01437 0.088 0.005 DB09157 0.097 0.005 DBMET03364 0.079 0.008 DBMET00507 | DBMET03364 | |
| 0.078 | 0.037 | 0.168 | Carbonic anhydrase V inhibitor | 0.127 0.02 DBMET01436 0.168 0.011 DBMET01437 0.07 0.042 DB09157 0.112 0.023 DBMET03364 0.082 0.034 DBMET00507 | DBMET01437 | |
| 0.046 | 0.006 | 0.092 | Glutamate (mGluR3) agonist | 0.055 0.004 DBMET01436 0.092 0.002 DBMET01437 0.042 0.008 DB09157 0.044 0.007 DBMET03364 0.043 0.008 DBMET00507 | DBMET01437 | |
| 0.086 | 0.046 | 0.117 | CC chemokine 5 receptor agonist | 0.098 0.024 DBMET01436 0.086 0.046 DBMET01437 0.102 0.019 DB09157 0.117 0.01 DBMET03364 | DBMET03364 | |
| 0.103 | 0.064 | 0.152 | Urease inhibitor | 0.129 0.037 DBMET01436 0.152 0.022 DBMET01437 0.102 0.064 DB09157 0.127 0.038 DBMET03364 0.142 0.027 DBMET00507 | DBMET01437 | |
| 0.108 | 0.07 | 0.252 | Monophenol monooxygenase inhibitor | 0.203 0.033 DBMET01436 0.252 0.024 DBMET01437 0.096 0.079 DBMET03364 0.139 0.052 DBMET00507 | DBMET01437 | |
| 0.132 | 0.094 | 0.165 | Pregnane X receptor agonist | 0.152 0.05 DBMET01436 0.14 0.074 DBMET01437 0.152 0.05 DB09157 0.165 0.032 DBMET03364 | DBMET03364 | |
| 0.047 | 0.009 | 0.078 | Uridine phosphorylase inhibitor | 0.06 0.005 DBMET01436 0.078 0.004 DBMET01437 0.049 0.008 DB09157 0.055 0.007 DBMET03364 0.026 0.021 DBMET00507 | DBMET01437 | |
| 0.062 | 0.024 | 0.088 | Leukotriene C antagonist | 0.07 0.014 DBMET01436 0.088 0.005 DBMET01437 0.058 0.035 DB09157 0.06 0.028 DBMET03364 0.071 0.013 DBMET00507 | DBMET01437 | |
| 0.06 | 0.022 | 0.089 | Heparanase inhibitor | 0.069 0.012 DBMET01436 0.089 0.005 DBMET01437 0.055 0.033 DB09157 0.055 0.034 DBMET03364 0.076 0.008 DBMET00507 | DBMET01437 | |
| 0.059 | 0.021 | 0.085 | Adenosine deaminase inhibitor | 0.078 0.01 DBMET01436 0.085 0.008 DBMET01437 0.06 0.021 DB09157 0.059 0.022 DBMET03364 0.061 0.019 DBMET00507 | DBMET01437 | |
| 0.053 | 0.015 | 0.109 | Dihydropteroate synthase inhibitor | 0.07 0.008 DBMET01436 0.109 0.004 DBMET01437 0.049 0.018 DB09157 0.047 0.019 DBMET03364 0.075 0.007 DBMET00507 | DBMET01437 | |
| 0.042 | 0.005 | 0.109 | Glutamate (mGluR1a) agonist | 0.084 0.004 DBMET01436 0.109 0.004 DBMET01437 0.05 0.005 DB09157 0.07 0.004 DBMET03364 0.061 0.004 DBMET00507 | DBMET01437 | |
| 0.046 | 0.009 | 0.071 | Retinoid X alpha receptor antagonist | 0.053 0.005 DBMET01436 0.071 0.003 DBMET01437 0.039 0.017 DB09157 0.046 0.009 DBMET03364 | DBMET01437 | |
| 0.098 | 0.061 | 0.175 | Sphingomyelinase inhibitor | 0.128 0.036 DBMET01436 0.127 0.036 DBMET01437 0.127 0.036 DB09157 0.175 0.016 DBMET03364 0.117 0.043 DBMET00507 | DBMET03364 | |
| 0.075 | 0.038 | 0.137 | Acetylcholine M5 receptor agonist | 0.1 0.02 DBMET01436 0.059 0.057 DBMET01437 0.106 0.017 DB09157 0.137 0.006 DBMET03364 | DBMET03364 | |
| 0.041 | 0.005 | 0.096 | Nicotinic acid receptor 2 antagonist | 0.051 0.004 DBMET01436 0.096 0.002 DBMET01437 0.037 0.006 DB09157 0.042 0.005 DBMET03364 | DBMET01437 | |
| 0.059 | 0.022 | 0.337 | CD45 antagonist | 0.08 0.012 DBMET01436 0.211 0.004 DBMET01437 0.047 0.042 DB09157 0.052 0.032 DBMET03364 0.337 0.004 DBMET00507 | DBMET00507 | |
| 0.051 | 0.014 | 0.208 | Nicotinic acid receptor agonist | 0.114 0.004 DBMET01436 0.208 0.003 DBMET01437 0.032 0.031 DB09157 0.039 0.021 DBMET03364 | DBMET01437 | |
| 0.051 | 0.015 | 0.097 | Alpha 1d adrenoreceptor agonist | 0.07 0.007 DBMET01436 0.052 0.015 DBMET01437 0.07 0.007 DB09157 0.097 0.004 DBMET03364 | DBMET03364 | |
| 0.068 | 0.032 | 0.188 | Xanthine dehydrogenase inhibitor | 0.093 0.018 DBMET01436 0.188 0.005 DBMET01437 | DBMET01437 | |
| 0.151 | 0.116 | 0.314 | DNA methylase inhibitor | 0.23 0.06 DBMET01436 0.314 0.024 DBMET01437 0.136 0.131 DB09157 0.216 0.069 DBMET03364 0.26 0.043 DBMET00507 | DBMET01437 | |
| 0.054 | 0.019 | 0.097 | AICAR transformylase inhibitor | 0.066 0.011 DBMET01436 0.085 0.006 DBMET01437 0.054 0.018 DB09157 0.051 0.022 DBMET03364 0.097 0.005 DBMET00507 | DBMET00507 | |
| 0.15 | 0.116 | 0.236 | Psychostimulant | 0.236 0.064 DBMET01436 0.227 0.067 DBMET01437 0.149 0.117 DB09157 0.226 0.068 DBMET03364 0.201 0.079 DBMET00507 | DBMET01436 | |
| 0.082 | 0.048 | 0.107 | Na+ K+ transporting ATPase inhibitor | 0.096 0.036 DBMET01436 0.098 0.033 DBMET01437 0.105 0.027 DB09157 0.107 0.025 DBMET03364 | DBMET03364 | |
| 0.067 | 0.034 | 0.089 | Calcium channel P-type blocker | 0.079 0.016 DBMET01436 0.075 0.02 DBMET01437 0.073 0.022 DB09157 0.089 0.009 DBMET03364 | DBMET03364 | |
| 0.076 | 0.044 | 0.091 | Potassium channel (Tandem pore domain) blocker | 0.087 0.021 DBMET01436 0.076 0.044 DBMET01437 0.084 0.026 DB09157 0.091 0.016 DBMET03364 0.088 0.02 DBMET00507 | DBMET03364 | |
| 0.115 | 0.083 | 0.149 | DNA repair enzyme inhibitor | 0.14 0.042 DBMET01436 0.149 0.032 DBMET01437 0.126 0.061 DB09157 0.134 0.049 DBMET03364 0.111 0.092 DBMET00507 | DBMET01437 | |
| 0.04 | 0.01 | 0.22 | NMDA 2D receptor antagonist | 0.076 0.004 DBMET01436 0.22 0.003 DBMET01437 | DBMET01437 | |
| 0.036 | 0.005 | 0.05 | Vanilloid 2 agonist | 0.042 0.004 DBMET01436 0.05 0.003 DBMET01437 0.037 0.005 DB09157 0.04 0.004 DBMET03364 | DBMET01437 | |
| 0.041 | 0.011 | 0.414 | Purinergic P2Y14 antagonist | 0.337 0.003 DBMET01436 0.414 0.003 DBMET01437 | DBMET01437 | |
| 0.049 | 0.019 | 0.066 | Histamine H1 receptor agonist | 0.057 0.011 DBMET01436 0.042 0.034 DBMET01437 0.058 0.01 DB09157 0.066 0.005 DBMET03364 | DBMET03364 | |
| 0.059 | 0.029 | 0.163 | Adenine nucleotide translocase inhibitor | 0.076 0.011 DBMET01436 0.163 0.003 DBMET01437 0.067 0.018 DBMET00507 | DBMET01437 | |
| 0.063 | 0.034 | 0.097 | Sphingosine 1-phosphate receptor 3 antagonist | 0.082 0.016 DBMET01436 0.097 0.009 DBMET01437 0.058 0.042 DB09157 0.065 0.032 DBMET03364 0.083 0.015 DBMET00507 | DBMET01437 | |
| 0.147 | 0.119 | 0.303 | Non-steroidal antiinflammatory agent | 0.22 0.057 DBMET01436 0.303 0.027 DBMET01437 0.264 0.037 DBMET03364 0.196 0.075 DBMET00507 | DBMET01437 | |
| 0.05 | 0.022 | 0.076 | Geranyltranstransferase inhibitor | 0.064 0.011 DBMET01436 0.076 0.005 DBMET01437 0.061 0.013 DB09157 0.068 0.009 DBMET03364 0.056 0.017 DBMET00507 | DBMET01437 | |
| 0.107 | 0.079 | 0.276 | Adenylate cyclase inhibitor | 0.151 0.044 DBMET01436 0.199 0.026 DBMET01437 0.122 0.066 DB09157 0.164 0.037 DBMET03364 0.276 0.016 DBMET00507 | DBMET00507 | |
| 0.035 | 0.007 | 0.231 | Retinoid X beta receptor agonist | 0.072 0.004 DBMET01436 0.231 0.002 DBMET01437 | DBMET01437 | |
| 0.072 | 0.044 | 0.108 | Protein kinase C beta inhibitor | 0.091 0.019 DBMET01436 0.108 0.01 DBMET01437 0.071 0.046 DB09157 0.083 0.026 DBMET03364 | DBMET01437 | |
| 0.046 | 0.019 | 0.092 | Membrane dipeptidase inhibitor | 0.055 0.012 DBMET01436 0.074 0.006 DBMET01437 0.055 0.012 DB09157 0.056 0.012 DBMET03364 0.092 0.004 DBMET00507 | DBMET00507 | |
| 0.066 | 0.039 | 0.085 | Transcription factor RelA inhibitor | 0.074 0.023 DBMET01436 0.066 0.037 DBMET01437 0.075 0.022 DB09157 0.085 0.013 DBMET03364 | DBMET03364 | |
| 0.048 | 0.021 | 0.066 | Angiotensin AT1 receptor antagonist | 0.063 0.005 DBMET01436 0.066 0.004 DBMET01437 0.04 0.033 DB09157 0.049 0.019 DBMET03364 0.045 0.024 DBMET00507 | DBMET01437 | |
| 0.035 | 0.008 | 0.149 | Retinoid X gamma receptor agonist | 0.07 0.004 DBMET01436 0.149 0.002 DBMET01437 | DBMET01437 | |
| 0.053 | 0.026 | 0.081 | Aldosterone antagonist | 0.073 0.013 DBMET01436 0.067 0.015 DBMET01437 0.056 0.023 DB09157 0.081 0.011 DBMET03364 | DBMET03364 | |
| 0.048 | 0.022 | 0.107 | GABA B receptor antagonist | 0.107 0.005 DBMET01436 0.071 0.008 DBMET01437 0.042 0.032 DB09157 0.05 0.019 DBMET03364 | DBMET01436 | |
| 0.04 | 0.015 | 0.094 | Tryptophan 5 hydroxylase inhibitor | 0.048 0.006 DBMET01436 0.057 0.004 DBMET01437 0.041 0.013 DB09157 0.044 0.009 DBMET03364 0.094 0.002 DBMET00507 | DBMET00507 | |
| 0.041 | 0.015 | 0.067 | Free fatty acid receptor 1 antagonist | 0.053 0.008 DBMET01436 0.067 0.005 DBMET01437 0.036 0.02 DB09157 0.044 0.013 DBMET03364 | DBMET01437 | |
| 0.038 | 0.013 | 0.049 | Epoxide hydrolase 1 inhibitor | 0.048 0.007 DBMET01436 0.049 0.006 DBMET01437 0.037 0.014 DB09157 0.042 0.009 DBMET03364 0.04 0.011 DBMET00507 | DBMET01437 | |
| 0.037 | 0.011 | 0.045 | Elastase 3A inhibitor | 0.045 0.006 DBMET01436 0.03 0.021 DBMET01437 | DBMET01436 | |
| 0.037 | 0.011 | 0.045 | Elastase 3B inhibitor | 0.045 0.006 DBMET01436 0.03 0.021 DBMET01437 | DBMET01436 | |
| 0.037 | 0.011 | 0.045 | Elastase 2B inhibitor | 0.045 0.006 DBMET01436 0.03 0.021 DBMET01437 | DBMET01436 | |
| 0.033 | 0.008 | 0.207 | Retinoic acid receptor agonist | 0.074 0.004 DBMET01436 0.207 0.003 DBMET01437 | DBMET01437 | |
| 0.029 | 0.004 | 0.05 | Carbonic anhydrase X inhibitor | 0.038 0.003 DBMET01436 0.05 0.003 DBMET01437 0.037 0.004 DB09157 0.028 0.005 DBMET03364 0.019 0.009 DBMET00507 | DBMET01437 | |
| 0.029 | 0.004 | 0.05 | Carbonic anhydrase VIII inhibitor | 0.038 0.003 DBMET01436 0.05 0.003 DBMET01437 0.037 0.004 DB09157 0.028 0.005 DBMET03364 0.019 0.009 DBMET00507 | DBMET01437 | |
| 0.107 | 0.082 | 0.16 | Interleukin 8 antagonist | 0.144 0.038 DBMET01436 0.16 0.028 DBMET01437 0.107 0.081 DB09157 0.128 0.052 DBMET03364 0.103 0.09 DBMET00507 | DBMET01437 | |
| 0.047 | 0.023 | 0.078 | Glutamate (mGluR1a) antagonist | 0.078 0.009 DBMET01436 0.066 0.013 DBMET01437 0.041 0.028 DB09157 0.052 0.019 DBMET03364 0.044 0.025 DBMET00507 | DBMET01436 | |
| 0.029 | 0.005 | 0.255 | Retinoic acid beta receptor agonist | 0.058 0.004 DBMET01436 0.255 0.002 DBMET01437 | DBMET01437 | |
| 0.029 | 0.005 | 0.064 | Retinoid X beta receptor antagonist | 0.034 0.004 DBMET01436 0.064 0.002 DBMET01437 0.024 0.008 DB09157 0.026 0.006 DBMET03364 | DBMET01437 | |
| 0.093 | 0.069 | 0.117 | Phosphodiesterase 6D inhibitor | 0.111 0.034 DBMET01436 0.117 0.028 DBMET01437 0.099 0.055 DB09157 0.106 0.042 DBMET03364 | DBMET01437 | |
| 0.031 | 0.007 | 0.036 | Complement factor 1s inhibitor | 0.036 0.004 DBMET01436 0.032 0.006 DBMET01437 0.033 0.005 DB09157 0.034 0.005 DBMET03364 | DBMET01436 | |
| 0.069 | 0.045 | 0.169 | Sphingosine 1-phosphate receptor 4 agonist | 0.106 0.022 DBMET01436 0.118 0.017 DBMET01437 0.088 0.031 DB09157 0.101 0.024 DBMET03364 0.169 0.006 DBMET00507 | DBMET00507 | |
| 0.042 | 0.018 | 0.054 | Vanilloid 3 antagonist | 0.051 0.008 DBMET01436 0.044 0.014 DBMET01437 0.046 0.012 DB09157 0.054 0.006 DBMET03364 | DBMET03364 | |
| 0.032 | 0.009 | 0.114 | Glutamate (mGluR1) agonist | 0.049 0.005 DBMET01436 0.114 0.003 DBMET01437 0.03 0.01 DB09157 0.036 0.006 DBMET03364 0.039 0.005 DBMET00507 | DBMET01437 | |
| 0.043 | 0.02 | 0.078 | Arginase inhibitor | 0.054 0.013 DBMET01436 0.078 0.006 DBMET01437 0.051 0.014 DB09157 0.048 0.016 DBMET03364 0.059 0.011 DBMET00507 | DBMET01437 | |
| 0.086 | 0.063 | 0.116 | Bromodomain-containing protein 2 inhibitor | 0.112 0.029 DBMET01436 0.099 0.042 DBMET01437 0.102 0.038 DB09157 0.116 0.026 DBMET03364 | DBMET03364 | |
| 0.054 | 0.031 | 0.074 | Prolyl endopeptidase inhibitor | 0.068 0.017 DBMET01436 0.066 0.018 DBMET01437 0.053 0.032 DB09157 0.074 0.013 DBMET03364 0.069 0.016 DBMET00507 | DBMET03364 | |
| 0.029 | 0.007 | 0.105 | Retinoic acid gamma receptor agonist | 0.04 0.004 DBMET01436 0.105 0.002 DBMET01437 | DBMET01437 | |
| 0.045 | 0.023 | 0.058 | Heme oxygenase inhibitor | 0.051 0.012 DBMET01436 0.046 0.019 DBMET01437 0.05 0.013 DB09157 0.058 0.007 DBMET03364 | DBMET03364 | |
| 0.052 | 0.031 | 0.115 | Carbonic anhydrase XIV inhibitor | 0.08 0.017 DBMET01436 0.115 0.008 DBMET01437 0.059 0.025 DBMET03364 0.067 0.021 DBMET00507 | DBMET01437 | |
| 0.146 | 0.124 | 0.254 | I kappa B kinase epsilon inhibitor | 0.2 0.071 DBMET01436 0.254 0.036 DBMET01437 0.175 0.094 DB09157 0.183 0.086 DBMET03364 | DBMET01437 | |
| 0.034 | 0.013 | 0.118 | Kynurenine 3 monooxygenase inhibitor | 0.052 0.006 DBMET01436 0.118 0.003 DBMET01437 0.026 0.019 DBMET03364 | DBMET01437 | |
| 0.027 | 0.006 | 0.049 | Neuraminidase (Influenza B) inhibitor | 0.038 0.003 DBMET01436 0.049 0.002 DBMET01437 0.025 0.008 DB09157 0.026 0.007 DBMET03364 0.021 0.014 DBMET00507 | DBMET01437 | |
| 0.083 | 0.062 | 0.115 | mTOR complex 2 inhibitor | 0.099 0.034 DBMET01436 0.094 0.041 DBMET01437 0.108 0.025 DB09157 0.115 0.02 DBMET03364 | DBMET03364 | |
| 0.037 | 0.017 | 0.085 | Protein kinase (CK2) beta inhibitor | 0.05 0.007 DBMET01436 0.085 0.004 DBMET01437 0.037 0.016 DB09157 0.047 0.008 DBMET03364 | DBMET01437 | |
| 0.027 | 0.008 | 0.123 | Retinoic acid alpha receptor antagonist | 0.044 0.004 DBMET01436 0.123 0.002 DBMET01437 | DBMET01437 | |
| 0.03 | 0.011 | 0.043 | Lysophosphatidic acid receptor 1 agonist | 0.036 0.007 DBMET01436 0.043 0.005 DBMET01437 0.035 0.008 DB09157 0.036 0.007 DBMET03364 0.032 0.01 DBMET00507 | DBMET01437 | |
| 0.036 | 0.018 | 0.052 | Calcium-independent phospholipase A2 inhibitor | 0.043 0.007 DBMET01436 0.052 0.004 DBMET01437 | DBMET01437 | |
| 0.03 | 0.012 | 0.053 | Retinoid X gamma receptor antagonist | 0.037 0.006 DBMET01436 0.053 0.003 DBMET01437 | DBMET01437 | |
| 0.041 | 0.023 | 0.063 | Leukotriene C4 antagonist | 0.047 0.013 DBMET01436 0.063 0.005 DBMET01437 0.037 0.032 DB09157 0.039 0.026 DBMET03364 0.046 0.014 DBMET00507 | DBMET01437 | |
| 0.041 | 0.023 | 0.057 | CF transmembrane conductance regulator antagonist | 0.048 0.01 DBMET01436 0.057 0.005 DBMET01437 0.041 0.024 DB09157 0.043 0.018 DBMET03364 | DBMET01437 | |
| 0.044 | 0.028 | 0.074 | Histamine H2 receptor agonist | 0.058 0.016 DBMET01436 0.07 0.01 DB09157 0.074 0.009 DBMET03364 | DBMET03364 | |
| 0.063 | 0.046 | 0.085 | Interferon inducer | 0.078 0.025 DBMET01436 0.085 0.02 DBMET01437 0.075 0.029 DB09157 0.081 0.023 DBMET03364 0.06 0.053 DBMET00507 | DBMET01437 | |
| 0.025 | 0.008 | 0.117 | Retinoic acid receptor antagonist | 0.044 0.004 DBMET01436 0.117 0.002 DBMET01437 | DBMET01437 | |
| 0.076 | 0.059 | 0.104 | Interferon agonist | 0.095 0.033 DBMET01436 0.104 0.025 DBMET01437 0.09 0.038 DB09157 0.098 0.03 DBMET03364 0.074 0.063 DBMET00507 | DBMET01437 | |
| 0.023 | 0.007 | 0.053 | Nicotinic acid receptor 1 antagonist | 0.03 0.004 DBMET01436 0.053 0.003 DBMET01437 0.022 0.007 DB09157 0.027 0.005 DBMET03364 | DBMET01437 | |
| 0.04 | 0.024 | 0.162 | TRPM8 blocker | 0.143 0.005 DBMET01436 0.162 0.004 DBMET01437 | DBMET01437 | |
| 0.03 | 0.014 | 0.053 | Prostaglandin H2 antagonist | 0.037 0.007 DBMET01436 0.053 0.004 DBMET01437 0.027 0.016 DBMET03364 0.035 0.009 DBMET00507 | DBMET01437 | |
| 0.048 | 0.032 | 0.065 | Cholesterol esterase inhibitor | 0.065 0.013 DBMET01436 0.055 0.023 DBMET01437 0.046 0.036 DB09157 0.057 0.02 DBMET03364 | DBMET01436 | |
| 0.12 | 0.104 | 0.286 | Diuretic | 0.269 0.028 DBMET01436 0.286 0.025 DBMET01437 0.218 0.038 DBMET03364 0.285 0.025 DBMET00507 | DBMET01437 | |
| 0.022 | 0.006 | 0.028 | Methylmalonyl-CoA mutase inhibitor | 0.024 0.004 DBMET01436 0.028 0.003 DBMET01437 0.023 0.005 DB09157 0.021 0.007 DBMET03364 0.021 0.008 DBMET00507 | DBMET01437 | |
| 0.039 | 0.023 | 0.082 | Integrin alpha2 antagonist | 0.049 0.012 DBMET01436 0.063 0.006 DBMET01437 0.038 0.023 DB09157 0.055 0.009 DBMET03364 0.082 0.004 DBMET00507 | DBMET00507 | |
| 0.04 | 0.024 | 0.098 | Farnesoid X receptor agonist | 0.057 0.011 DBMET01436 0.098 0.004 DBMET01437 0.034 0.031 DBMET03364 0.035 0.03 DBMET00507 | DBMET01437 | |
| 0.054 | 0.039 | 0.101 | Thromboxane synthase inhibitor | 0.082 0.011 DBMET01436 0.101 0.006 DBMET01437 0.05 0.047 DBMET03364 0.086 0.009 DBMET00507 | DBMET01437 | |
| 0.103 | 0.087 | 0.171 | Caspase 3 inhibitor | 0.132 0.044 DBMET01436 0.163 0.02 DBMET01437 0.103 0.086 DB09157 0.128 0.049 DBMET03364 0.171 0.017 DBMET00507 | DBMET00507 | |
| 0.106 | 0.091 | 0.136 | Transcription factor STAT6 inhibitor | 0.13 0.043 DBMET01436 0.134 0.039 DBMET01437 0.124 0.054 DB09157 0.136 0.036 DBMET03364 0.112 0.075 DBMET00507 | DBMET03364 | |
| 0.026 | 0.011 | 0.045 | Protease (Human cytomegalovirus) inhibitor | 0.04 0.005 DBMET01436 0.045 0.005 DBMET01437 0.025 0.011 DB09157 0.031 0.007 DBMET03364 | DBMET01437 | |
| 0.033 | 0.02 | 0.061 | ATP citrate lysase inhibitor | 0.043 0.011 DBMET01436 0.061 0.005 DBMET01437 0.033 0.021 DB09157 0.043 0.011 DBMET03364 | DBMET01437 | |
| 0.033 | 0.02 | 0.05 | Methionyl aminopeptidase 1 inhibitor | 0.046 0.008 DBMET01436 0.05 0.006 DBMET01437 0.033 0.021 DB09157 0.036 0.016 DBMET03364 0.029 0.028 DBMET00507 | DBMET01437 | |
| 0.049 | 0.035 | 0.116 | Topoisomerase II beta inhibitor | 0.067 0.018 DBMET01436 0.116 0.007 DBMET01437 0.055 0.027 DB09157 0.068 0.018 DBMET03364 0.078 0.014 DBMET00507 | DBMET01437 | |
| 0.031 | 0.017 | 0.052 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.04 0.012 DBMET01436 0.042 0.011 DBMET01437 0.052 0.008 DB09157 0.04 0.012 DBMET03364 0.037 0.013 DBMET00507 | DB09157 | |
| 0.054 | 0.04 | 0.091 | Epithelial sodium channel blocker | 0.067 0.02 DBMET01436 0.061 0.028 DBMET01437 0.063 0.025 DB09157 0.066 0.021 DBMET03364 0.091 0.009 DBMET00507 | DBMET00507 | |
| 0.04 | 0.027 | 0.107 | AMPA 4 receptor antagonist | 0.053 0.013 DBMET01436 0.107 0.005 DBMET01437 0.039 0.028 DB09157 0.045 0.02 DBMET03364 0.04 0.027 DBMET00507 | DBMET01437 | |
| 0.035 | 0.022 | 0.067 | Angiotensin II receptor antagonist | 0.057 0.005 DBMET01436 0.067 0.004 DBMET01437 0.036 0.02 DBMET03364 0.034 0.024 DBMET00507 | DBMET01437 | |
| 0.03 | 0.017 | 0.039 | Estrogen-related receptor gamma antagonist | 0.035 0.009 DBMET01436 0.037 0.007 DBMET01437 0.034 0.009 DB09157 0.039 0.005 DBMET03364 | DBMET03364 | |
| 0.057 | 0.044 | 0.119 | Carbonic anhydrase stimulant | 0.074 0.029 DBMET01436 0.074 0.029 DBMET01437 0.075 0.029 DB09157 0.078 0.027 DBMET03364 0.119 0.014 DBMET00507 | DBMET00507 | |
| 0.036 | 0.024 | 0.075 | Glutamate (mGluR8) antagonist | 0.047 0.01 DBMET01436 0.075 0.004 DBMET01437 0.038 0.021 DBMET00507 | DBMET01437 | |
| 0.043 | 0.03 | 0.13 | Glutamate (mGluR group III) agonist | 0.078 0.014 DBMET01436 0.13 0.006 DBMET01437 0.041 0.033 DB09157 0.056 0.02 DBMET03364 0.044 0.029 DBMET00507 | DBMET01437 | |
| 0.028 | 0.016 | 0.047 | Integrin alpha2beta1 antagonist | 0.035 0.008 DBMET01436 0.047 0.005 DBMET01437 0.028 0.015 DB09157 0.04 0.006 DBMET03364 0.04 0.006 DBMET00507 | DBMET01437 | |
| 0.03 | 0.018 | 0.047 | Purinergic P2Y15 antagonist | 0.035 0.011 DBMET01436 0.033 0.013 DBMET01437 0.047 0.004 DB09157 0.043 0.005 DBMET03364 0.033 0.012 DBMET00507 | DB09157 | |
| 0.047 | 0.035 | 0.057 | Benzodiazepine antagonist | 0.057 0.016 DBMET01436 0.045 0.038 DBMET01437 0.045 0.039 DB09157 0.049 0.03 DBMET03364 | DBMET01436 | |
| 0.11 | 0.099 | 0.185 | Alkaline phosphatase inhibitor | 0.153 0.058 DBMET01436 0.185 0.039 DBMET01437 0.136 0.07 DBMET03364 0.143 0.065 DBMET00507 | DBMET01437 | |
| 0.163 | 0.152 | 0.327 | Spasmolytic | 0.327 0.06 DBMET01436 0.321 0.062 DBMET01437 0.246 0.093 DBMET03364 0.191 0.128 DBMET00507 | DBMET01436 | |
| 0.034 | 0.022 | 0.042 | Melatonin receptor 1A agonist | 0.042 0.012 DBMET01436 0.038 0.016 DBMET01437 0.037 0.018 DB09157 0.042 0.012 DBMET03364 0.031 0.03 DBMET00507 | DBMET03364 | |
| 0.182 | 0.171 | 0.296 | 12-Lipoxygenase inhibitor | 0.254 0.107 DBMET01436 0.296 0.082 DBMET01437 0.201 0.15 DBMET03364 | DBMET01437 | |
| 0.045 | 0.034 | 0.058 | Purinergic P2X4 antagonist | 0.058 0.016 DBMET01436 0.057 0.017 DBMET01437 0.047 0.03 DB09157 0.055 0.018 DBMET03364 | DBMET01436 | |
| 0.179 | 0.169 | 0.335 | Transcription factor STAT inhibitor | 0.269 0.075 DBMET01436 0.335 0.04 DBMET01437 0.263 0.078 DBMET03364 0.215 0.118 DBMET00507 | DBMET01437 | |
| 0.015 | 0.005 | 0.041 | Glutamate (mGluR6) agonist | 0.021 0.004 DBMET01436 0.041 0.002 DBMET01437 0.019 0.004 DB09157 0.018 0.004 DBMET03364 0.011 0.01 DBMET00507 | DBMET01437 | |
| 0.037 | 0.027 | 0.053 | Diamine oxidase inhibitor | 0.053 0.013 DBMET01436 0.053 0.013 DBMET01437 0.04 0.023 DB09157 0.048 0.016 DBMET03364 | DBMET01437 | |
| 0.038 | 0.028 | 0.114 | Urate transporter 1 inhibitor | 0.079 0.008 DBMET01436 0.114 0.005 DBMET01437 | DBMET01437 | |
| 0.015 | 0.006 | 0.022 | Carbonic anhydrase XI inhibitor | 0.02 0.004 DBMET01436 0.022 0.004 DBMET01437 0.018 0.005 DB09157 0.015 0.006 DBMET03364 | DBMET01437 | |
| 0.015 | 0.006 | 0.138 | Retinoic acid beta receptor antagonist | 0.03 0.004 DBMET01436 0.138 0.002 DBMET01437 | DBMET01437 | |
| 0.026 | 0.017 | 0.032 | Complement factor 1r inhibitor | 0.032 0.009 DBMET01436 | DBMET01436 | |
| 0.21 | 0.202 | 0.356 | 15-Lipoxygenase inhibitor | 0.356 0.096 DBMET01436 0.324 0.115 DBMET01437 0.256 0.16 DBMET03364 0.209 0.204 DBMET00507 | DBMET01436 | |
| 0.057 | 0.049 | 0.12 | NMDA 2C receptor antagonist | 0.081 0.025 DBMET01436 0.12 0.01 DBMET01437 0.073 0.03 DBMET03364 0.088 0.021 DBMET00507 | DBMET01437 | |
| 0.042 | 0.035 | 0.069 | Fructose-1,6-bisphosphatase inhibitor | 0.059 0.018 DBMET01436 0.069 0.013 DBMET01437 0.046 0.029 DB09157 0.05 0.024 DBMET03364 | DBMET01437 | |
| 0.04 | 0.033 | 0.071 | Leukocyte elastase inhibitor | 0.065 0.016 DBMET01436 0.071 0.014 DBMET01437 0.057 0.02 DBMET00507 | DBMET01437 | |
| 0.013 | 0.006 | 0.125 | Retinoic acid receptor gamma antagonist | 0.025 0.004 DBMET01436 0.125 0.002 DBMET01437 | DBMET01437 | |
| 0.014 | 0.007 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.019 0.004 DBMET01436 0.015 0.006 DBMET01437 0.02 0.004 DB09157 0.02 0.004 DBMET03364 0.02 0.004 DBMET00507 | DBMET00507 | |
| 0.026 | 0.019 | 0.146 | Lysine carboxypeptidase inhibitor | 0.033 0.014 DBMET01436 0.043 0.009 DBMET01437 0.033 0.013 DB09157 0.033 0.014 DBMET03364 0.146 0.003 DBMET00507 | DBMET00507 | |
| 0.033 | 0.026 | 0.071 | Phosphoglycerate kinase inhibitor | 0.045 0.016 DBMET01436 0.071 0.009 DBMET01437 0.042 0.018 DB09157 0.043 0.017 DBMET03364 | DBMET01437 | |
| 0.014 | 0.007 | 0.026 | Human herpes virus 5 capsid protein P40 inhibitor | 0.021 0.004 DBMET01436 0.026 0.004 DBMET01437 0.013 0.009 DBMET03364 | DBMET01437 | |
| 0.026 | 0.019 | 0.033 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.03 0.011 DBMET01436 0.029 0.012 DBMET01437 0.031 0.01 DB09157 0.033 0.008 DBMET03364 | DBMET03364 | |
| 0.015 | 0.008 | 0.024 | Lysophosphatidic acid receptor 3 agonist | 0.019 0.005 DBMET01436 0.024 0.004 DBMET01437 0.023 0.005 DB09157 0.022 0.005 DBMET03364 | DBMET01437 | |
| 0.059 | 0.053 | 0.074 | Histone deacetylase SIRT3 inhibitor | 0.067 0.032 DBMET01436 0.065 0.037 DB09157 0.067 0.033 DBMET03364 0.074 0.023 DBMET00507 | DBMET00507 | |
| 0.05 | 0.044 | 0.102 | Leukotriene B4 antagonist | 0.076 0.017 DBMET01436 0.102 0.01 DBMET01437 | DBMET01437 | |
| 0.016 | 0.01 | 0.023 | Thromboxane A2 agonist | 0.02 0.006 DBMET01436 0.021 0.005 DBMET01437 0.021 0.005 DB09157 0.023 0.004 DBMET03364 0.02 0.005 DBMET00507 | DBMET03364 | |
| 0.058 | 0.052 | 0.106 | 5 Hydroxytryptamine 3 agonist | 0.079 0.028 DBMET01436 0.079 0.028 DB09157 0.106 0.013 DBMET03364 | DBMET03364 | |
| 0.021 | 0.015 | 0.056 | Lysophosphatidic acid 1 receptor antagonist | 0.027 0.008 DBMET01436 0.056 0.004 DBMET01437 0.021 0.015 DBMET00507 | DBMET01437 | |
| 0.017 | 0.012 | 0.025 | Telomerase stimulant | 0.02 0.008 DBMET01436 0.021 0.007 DBMET01437 0.025 0.004 DB09157 0.025 0.004 DBMET03364 | DBMET03364 | |
| 0.025 | 0.02 | 0.068 | Calcium-sensing receptor agonist | 0.036 0.009 DBMET01436 0.068 0.004 DBMET01437 0.067 0.004 DBMET00507 | DBMET01437 | |
| 0.088 | 0.084 | 0.198 | Mediator release inhibitor | 0.171 0.021 DBMET01436 0.198 0.015 DBMET01437 0.11 0.058 DBMET00507 | DBMET01437 | |
| 0.009 | 0.005 | 0.03 | Mannitol 2-dehydrogenase inhibitor | 0.013 0.003 DBMET01436 0.03 0.001 DBMET01437 | DBMET01437 | |
| 0.067 | 0.062 | 0.111 | Peroxisome proliferator-activated receptor gamma antagonist | 0.092 0.02 DBMET01436 0.111 0.011 DBMET01437 0.099 0.016 DBMET00507 | DBMET01437 | |
| 0.032 | 0.028 | 0.067 | Glutamate (mGluR4) agonist | 0.043 0.014 DBMET01436 0.067 0.007 DBMET01437 0.032 0.029 DB09157 0.037 0.019 DBMET03364 | DBMET01437 | |
| 0.036 | 0.033 | 0.156 | Kainate receptor antagonist | 0.061 0.016 DBMET01436 0.156 0.004 DBMET01437 0.044 0.025 DBMET00507 | DBMET01437 | |
| 0.033 | 0.03 | 0.118 | 5-Alpha-reductase inhibitor | 0.054 0.017 DBMET01436 0.118 0.008 DBMET01437 0.034 0.03 DBMET03364 0.035 0.028 DBMET00507 | DBMET01437 | |
| 0.026 | 0.023 | 0.038 | Hedgehog signaling activator | 0.03 0.012 DBMET01436 0.03 0.013 DBMET01437 0.036 0.006 DB09157 0.038 0.005 DBMET03364 | DBMET03364 | |
| 0.031 | 0.028 | 0.061 | Carnitine palmitoyltransferase 1 inhibitor | 0.05 0.007 DBMET01436 0.061 0.005 DBMET01437 0.033 0.026 DBMET00507 | DBMET01437 | |
| 0.028 | 0.025 | 0.057 | Lysophosphatidic acid 2 receptor antagonist | 0.04 0.013 DBMET01436 0.057 0.007 DBMET01437 0.032 0.019 DB09157 0.04 0.012 DBMET03364 0.033 0.018 DBMET00507 | DBMET01437 | |
| 0.021 | 0.019 | 0.031 | Prostaglandin F2 alpha agonist | 0.026 0.012 DBMET01436 0.03 0.009 DBMET01437 0.027 0.011 DB09157 0.031 0.008 DBMET03364 | DBMET03364 | |
| 0.122 | 0.119 | 0.15 | Neuropeptide Y1 antagonist | 0.15 0.065 DBMET01436 0.146 0.071 DBMET01437 0.126 0.108 DB09157 0.145 0.073 DBMET03364 | DBMET01436 | |
| 0.026 | 0.024 | 0.037 | Glucosylceramidase stimulant | 0.037 0.005 DBMET01436 0.031 0.011 DB09157 0.033 0.008 DBMET03364 | DBMET01436 | |
| 0.031 | 0.029 | 0.063 | Carnitine palmitoyltransferase inhibitor | 0.052 0.008 DBMET01436 0.063 0.005 DBMET01437 0.034 0.024 DBMET00507 | DBMET01437 | |
| 0.02 | 0.018 | 0.064 | Prostaglandin EP2 agonist | 0.035 0.01 DBMET01436 0.064 0.004 DBMET01437 0.021 0.017 DBMET00507 | DBMET01437 | |
| 0.007 | 0.005 | 0.01 | DNA topoisomerase III inhibitor | 0.009 0.004 DBMET01436 0.008 0.005 DBMET01437 0.009 0.004 DB09157 0.01 0.004 DBMET03364 | DBMET03364 | |
| 0.024 | 0.022 | 0.034 | Acid ceramidase inhibitor | 0.029 0.01 DBMET01436 0.031 0.008 DB09157 0.034 0.006 DBMET03364 | DBMET03364 | |
| 0.016 | 0.014 | 0.03 | Aminopeptidase A inhibitor | 0.02 0.011 DBMET01436 0.03 0.006 DBMET01437 0.02 0.011 DBMET00507 | DBMET01437 | |
| 0.031 | 0.029 | 0.1 | Kainate receptor 2 antagonist | 0.053 0.014 DBMET01436 0.1 0.005 DBMET01437 0.033 0.028 DB09157 0.043 0.02 DBMET03364 0.037 0.024 DBMET00507 | DBMET01437 | |
| 0.037 | 0.035 | 0.058 | Oxytocin agonist | 0.048 0.025 DBMET01436 0.042 0.03 DBMET01437 0.058 0.019 DB09157 0.058 0.019 DBMET03364 0.039 0.033 DBMET00507 | DBMET03364 | |
| 0.053 | 0.052 | 0.097 | Androgen agonist | 0.073 0.028 DBMET01436 0.073 0.028 DBMET01437 0.067 0.034 DB09157 0.097 0.016 DBMET03364 0.054 0.049 DBMET00507 | DBMET03364 | |
| 0.046 | 0.045 | 0.067 | Potassium channel (Inward rectifier) activator | 0.059 0.021 DBMET01436 0.05 0.037 DBMET01437 0.061 0.019 DB09157 0.067 0.014 DBMET03364 | DBMET03364 | |
| 0.011 | 0.01 | 0.088 | Egl nine homolog 3 inhibitor | 0.017 0.005 DBMET01436 0.037 0.003 DBMET01437 0.088 0.002 DBMET00507 | DBMET00507 | |
| 0.031 | 0.03 | 0.052 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.037 0.019 DBMET01436 0.052 0.008 DBMET01437 | DBMET01437 | |
| 0.018 | 0.017 | 0.024 | Antibiotic Anthracycline-like | 0.021 0.01 DBMET01436 0.022 0.008 DBMET01437 0.023 0.007 DB09157 0.024 0.005 DBMET03364 | DBMET03364 | |
| 0.044 | 0.043 | 0.064 | Potassium channel (ATP-sensitive) activator | 0.056 0.02 DBMET01436 0.047 0.035 DBMET01437 0.058 0.018 DB09157 0.064 0.013 DBMET03364 | DBMET03364 | |
| 0.021 | 0.021 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.025 0.012 DBMET01436 0.026 0.009 DBMET01437 0.026 0.01 DB09157 0.026 0.01 DBMET03364 | DBMET03364 | |
| 0.027 | 0.027 | 0.089 | Prostaglandin agonist | 0.054 0.009 DBMET01436 0.089 0.006 DBMET01437 0.028 0.025 DBMET03364 | DBMET01437 | |
| 0.026 | 0.027 | 0.052 | Nicotinic alpha3beta4 receptor agonist | 0.035 0.015 DBMET01436 0.042 0.009 DB09157 0.052 0.005 DBMET03364 | DBMET03364 | |
| 0.037 | 0.037 | 0.054 | Thymidine kinase inhibitor | 0.046 0.022 DBMET01436 0.047 0.021 DBMET01437 0.05 0.019 DB09157 0.054 0.016 DBMET03364 0.048 0.02 DBMET00507 | DBMET03364 | |
| 0.041 | 0.042 | 0.058 | Glutamate (mGluR5) agonist | 0.056 0.02 DBMET01436 0.047 0.03 DBMET01437 0.044 0.034 DB09157 0.058 0.019 DBMET03364 | DBMET03364 | |
| 0.016 | 0.017 | 0.023 | CXC chemokine 5 receptor antagonist | 0.02 0.008 DBMET01436 0.023 0.005 DBMET01437 0.02 0.009 DBMET03364 | DBMET01437 | |
| 0.052 | 0.053 | 0.073 | Botulinum neurotoxin type A inhibitor | 0.066 0.03 DBMET01436 0.061 0.036 DBMET01437 0.054 0.048 DB09157 0.059 0.039 DBMET03364 0.073 0.022 DBMET00507 | DBMET00507 | |
| 0.024 | 0.025 | 0.059 | Liver X receptor beta antagonist | 0.041 0.012 DBMET01436 0.059 0.006 DBMET01437 0.026 0.023 DBMET03364 | DBMET01437 | |
| 0.011 | 0.013 | 0.102 | Prostaglandin EP4 agonist | 0.058 0.005 DBMET01436 0.102 0.004 DBMET01437 | DBMET01437 | |
| 0.056 | 0.058 | 0.075 | Heme oxygenase stimulant | 0.067 0.03 DBMET01436 0.075 0.019 DBMET01437 | DBMET01437 | |
| 0.021 | 0.023 | 0.094 | Methionyl aminopeptidase 2 inhibitor | 0.041 0.009 DBMET01436 0.094 0.004 DBMET01437 0.024 0.019 DBMET03364 | DBMET01437 | |
| 0.036 | 0.038 | 0.058 | Liver X receptor alpha agonist | 0.045 0.024 DBMET01436 0.058 0.014 DBMET01437 0.042 0.027 DBMET03364 | DBMET01437 | |
| 0.016 | 0.018 | 0.105 | 5-Alpha-reductase 2 inhibitor | 0.025 0.01 DBMET01436 0.105 0.005 DBMET01437 | DBMET01437 | |
| 0.03 | 0.032 | 0.107 | RNA-directed RNA polymerase inhibitor | 0.046 0.015 DBMET01436 0.107 0.005 DBMET01437 0.064 0.009 DBMET00507 | DBMET01437 | |
| 0.009 | 0.011 | 0.017 | Thromboxane agonist | 0.012 0.006 DBMET01436 0.017 0.004 DBMET01437 0.01 0.008 DB09157 0.012 0.006 DBMET03364 | DBMET01437 | |
| 0.034 | 0.036 | 0.051 | Potassium channel Kv1.1 blocker | 0.043 0.019 DBMET01436 0.046 0.016 DB09157 0.051 0.013 DBMET03364 | DBMET03364 | |
| 0.04 | 0.042 | 0.126 | Thymidylate synthase inhibitor | 0.062 0.015 DBMET01436 0.068 0.013 DBMET01437 0.047 0.031 DB09157 0.046 0.033 DBMET03364 0.126 0.004 DBMET00507 | DBMET00507 | |
| 0.011 | 0.014 | 0.03 | Angiotensin AT1B receptor antagonist | 0.024 0.005 DBMET01436 0.03 0.004 DBMET01437 | DBMET01437 | |
| 0.04 | 0.043 | 0.063 | Glutamate (mGluR group I) agonist | 0.063 0.02 DBMET01436 0.06 0.022 DBMET01437 0.042 0.04 DB09157 0.06 0.022 DBMET03364 | DBMET01436 | |
| 0.017 | 0.021 | 0.037 | Imidazoline I1 receptor antagonist | 0.025 0.01 DBMET01436 0.022 0.013 DB09157 0.037 0.005 DBMET03364 | DBMET03364 | |
| 0.024 | 0.027 | 0.081 | LFA antagonist | 0.034 0.012 DBMET01436 0.062 0.005 DBMET01437 0.027 0.02 DBMET03364 0.081 0.004 DBMET00507 | DBMET00507 | |
| 0.013 | 0.017 | 0.019 | Purinergic P2Y1 agonist | 0.015 0.012 DBMET01436 0.014 0.013 DBMET01437 0.019 0.007 DB09157 0.017 0.008 DBMET03364 | DB09157 | |
| 0.018 | 0.023 | 0.028 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.011 DBMET01436 0.021 0.013 DBMET01437 0.025 0.007 DB09157 0.028 0.005 DBMET03364 | DBMET03364 | |
| 0.02 | 0.024 | 0.027 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.026 0.012 DBMET01436 0.027 0.01 DBMET01437 0.023 0.017 DB09157 0.025 0.014 DBMET03364 | DBMET01437 | |
| 0.131 | 0.135 | 0.513 | Angiogenesis stimulant | 0.513 0.011 DBMET01436 0.248 0.071 DBMET01437 0.281 0.057 DBMET00507 | DBMET01436 | |
| 0.004 | 0.009 | 0.008 | CC chemokine 6 receptor agonist | 0.006 0.005 DBMET01436 0.006 0.004 DB09157 0.008 0.003 DBMET03364 | DBMET03364 | |
| 0.087 | 0.092 | 0.195 | AMP-activated protein kinase stimulant | 0.128 0.042 DBMET01436 0.195 0.012 DBMET01437 0.12 0.049 DBMET03364 0.123 0.046 DBMET00507 | DBMET01437 | |
| 0.044 | 0.049 | 0.105 | Thromboxane antagonist | 0.087 0.016 DBMET01436 0.105 0.01 DBMET01437 0.049 0.042 DBMET03364 0.067 0.028 DBMET00507 | DBMET01437 | |
| 0.04 | 0.045 | 0.094 | Thromboxane A2 antagonist | 0.08 0.015 DBMET01436 0.094 0.009 DBMET01437 0.045 0.04 DBMET03364 0.063 0.026 DBMET00507 | DBMET01437 | |
| 0.023 | 0.028 | 0.031 | Thymidine phosphorylase inhibitor | 0.027 0.016 DBMET01436 0.028 0.014 DBMET01437 0.031 0.011 DB09157 0.03 0.012 DBMET03364 | DB09157 | |
| 0.043 | 0.048 | 0.065 | Bombesin 2 receptor antagonist | 0.05 0.033 DBMET01436 0.055 0.027 DBMET01437 0.049 0.034 DB09157 0.05 0.033 DBMET03364 0.065 0.022 DBMET00507 | DBMET00507 | |
| 0.015 | 0.02 | 0.097 | Kainate receptor 1 antagonist | 0.03 0.01 DBMET01436 0.097 0.004 DBMET01437 | DBMET01437 | |
| 0.054 | 0.06 | 0.129 | Leukotriene antagonist | 0.099 0.022 DBMET01436 0.129 0.014 DBMET01437 0.064 0.046 DBMET03364 0.069 0.041 DBMET00507 | DBMET01437 | |
| 0.018 | 0.024 | 0.063 | Prostaglandin E2 agonist | 0.038 0.008 DBMET01436 0.063 0.005 DBMET01437 | DBMET01437 | |
| 0.015 | 0.021 | 0.022 | Complement factor D inhibitor | 0.02 0.009 DBMET01436 0.02 0.01 DBMET01437 0.018 0.012 DB09157 0.022 0.007 DBMET03364 | DBMET03364 | |
| 0.036 | 0.042 | 0.146 | NMDA receptor subunit 3B antagonist | 0.056 0.021 DBMET01436 0.146 0.006 DBMET01437 0.071 0.015 DBMET03364 0.052 0.024 DBMET00507 | DBMET01437 | |
| 0.005 | 0.011 | 0.009 | Integrin alpha5beta6 antagonist | 0.006 0.005 DBMET01436 0.006 0.005 DBMET01437 0.006 0.005 DB09157 0.007 0.005 DBMET03364 0.009 0.003 DBMET00507 | DBMET00507 | |
| 0.008 | 0.015 | 0.014 | Imidazoline I2 receptor antagonist | 0.011 0.007 DBMET01436 0.014 0.005 DBMET03364 | DBMET03364 | |
| 0.035 | 0.042 | 0.203 | Phosphorylase inhibitor | 0.077 0.018 DBMET01436 0.129 0.009 DBMET01437 0.203 0.005 DBMET00507 | DBMET00507 | |
| 0.018 | 0.025 | 0.062 | NMDA receptor glycine site antagonist | 0.029 0.013 DBMET01436 0.062 0.005 DBMET01437 0.024 0.017 DBMET00507 | DBMET01437 | |
| 0.043 | 0.051 | 0.061 | Cytokine production stimulant | 0.052 0.024 DBMET01436 0.047 0.038 DBMET01437 0.056 0.018 DB09157 0.061 0.012 DBMET03364 | DBMET03364 | |
| 0.02 | 0.027 | 0.098 | Prostaglandin EP4 antagonist | 0.05 0.008 DBMET01436 0.098 0.004 DBMET01437 0.03 0.015 DBMET00507 | DBMET01437 | |
| 0.015 | 0.023 | 0.034 | Estrogen-related receptor gamma agonist | 0.019 0.013 DBMET01436 0.019 0.012 DBMET01437 0.017 0.016 DB09157 0.018 0.014 DBMET03364 0.034 0.004 DBMET00507 | DBMET00507 | |
| 0.011 | 0.018 | 0.086 | 5-Alpha-reductase 1 inhibitor | 0.023 0.01 DBMET01436 0.086 0.005 DBMET01437 | DBMET01437 | |
| 0.073 | 0.08 | 0.095 | Caspase 7 inhibitor | 0.094 0.036 DBMET01436 0.088 0.045 DBMET01437 0.087 0.047 DB09157 0.095 0.034 DBMET03364 0.088 0.045 DBMET00507 | DBMET03364 | |
| 0.007 | 0.015 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 DB09157 | DB09157 | |
| 0.018 | 0.026 | 0.024 | Factor XIII inhibitor | 0.021 0.015 DBMET01436 0.023 0.01 DB09157 0.024 0.009 DBMET03364 | DBMET03364 | |
| 0.071 | 0.079 | 0.122 | Inducible nitric-oxide synthase inhibitor | 0.09 0.047 DBMET01436 0.081 0.06 DBMET01437 0.074 0.073 DB09157 0.122 0.024 DBMET03364 | DBMET03364 | |
| 0.048 | 0.056 | 0.073 | Fatty acid synthase inhibitor | 0.069 0.026 DBMET01436 0.073 0.023 DBMET01437 0.06 0.035 DBMET03364 | DBMET01437 | |
| 0.008 | 0.017 | 0.022 | Thrombopoietin agonist | 0.016 0.005 DBMET01436 0.022 0.004 DBMET01437 | DBMET01437 | |
| 0.081 | 0.09 | 0.177 | Interleukin 1 beta converting enzyme inhibitor | 0.113 0.042 DBMET01436 0.126 0.03 DBMET01437 0.089 0.073 DB09157 0.129 0.028 DBMET03364 0.177 0.009 DBMET00507 | DBMET00507 | |
| 0.014 | 0.023 | 0.017 | CC chemokine 9 receptor antagonist | 0.017 0.013 DBMET01436 0.016 0.014 DBMET01437 0.016 0.015 DB09157 | DBMET01436 | |
| 0.02 | 0.029 | 0.04 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.031 0.017 DBMET01436 0.038 0.012 DBMET01437 0.04 0.011 DBMET03364 | DBMET03364 | |
| 0.024 | 0.034 | 0.044 | Sirtuin 2 inhibitor | 0.044 0.015 DBMET01436 0.036 0.02 DBMET03364 0.033 0.023 DBMET00507 | DBMET01436 | |
| 0.036 | 0.046 | 0.075 | Carbonic anhydrase VII inhibitor | 0.054 0.024 DBMET01436 0.075 0.014 DBMET01437 0.041 0.039 DBMET03364 0.059 0.02 DBMET00507 | DBMET01437 | |
| 0.019 | 0.029 | 0.048 | ICAM 1 antagonist | 0.025 0.012 DBMET01436 0.029 0.007 DBMET01437 0.048 0.004 DBMET00507 | DBMET00507 | |
| 0.037 | 0.047 | 0.056 | Potassium channel Kv1.3 blocker | 0.056 0.024 DBMET01436 0.043 0.038 DBMET01437 0.041 0.04 DB09157 0.053 0.026 DBMET03364 0.055 0.025 DBMET00507 | DBMET01436 | |
| 0.046 | 0.057 | 0.085 | Sphingosine kinase 2 inhibitor | 0.061 0.03 DBMET01436 0.062 0.029 DBMET01437 0.067 0.024 DB09157 0.085 0.013 DBMET03364 | DBMET03364 | |
| 0.024 | 0.035 | 0.091 | HCV NS5B polymerase inhibitor | 0.037 0.016 DBMET01436 0.091 0.005 DBMET01437 0.046 0.011 DBMET00507 | DBMET01437 | |
| 0.028 | 0.039 | 0.036 | Carboxypeptidase B inhibitor | 0.031 0.026 DBMET01436 0.035 0.019 DBMET01437 0.031 0.027 DB09157 0.031 0.026 DBMET03364 0.036 0.017 DBMET00507 | DBMET00507 | |
| 0.04 | 0.051 | 0.137 | Dihydroorotate dehydrogenase inhibitor | 0.09 0.014 DBMET01436 0.137 0.005 DBMET01437 | DBMET01437 | |
| 0.006 | 0.018 | 0.013 | Progesterone receptor A antagonist | 0.013 0.004 DBMET03364 | DBMET03364 | |
| 0.071 | 0.083 | 0.108 | Myeloperoxidase inhibitor | 0.095 0.042 DBMET01436 0.105 0.029 DBMET01437 0.085 0.057 DB09157 0.108 0.027 DBMET03364 | DBMET03364 | |
| 0.024 | 0.036 | 0.052 | Calcitonin receptor agonist | 0.029 0.028 DBMET01436 0.029 0.028 DBMET01437 0.033 0.024 DB09157 0.03 0.027 DBMET03364 0.052 0.016 DBMET00507 | DBMET00507 | |
| 0.041 | 0.054 | 0.061 | HCV NS3/NS4A protease inhibitor | 0.05 0.032 DBMET01436 0.052 0.029 DBMET01437 0.049 0.033 DB09157 0.061 0.02 DBMET03364 0.054 0.027 DBMET00507 | DBMET03364 | |
| 0.032 | 0.044 | 0.1 | Carbonic anhydrase IV inhibitor | 0.05 0.025 DBMET01436 0.063 0.018 DBMET01437 0.041 0.031 DBMET03364 0.1 0.007 DBMET00507 | DBMET00507 | |
| 0.009 | 0.022 | 0.099 | Egl nine homolog 1 inhibitor | 0.015 0.01 DBMET01436 0.037 0.004 DBMET01437 0.099 0.002 DBMET00507 | DBMET00507 | |
| 0.174 | 0.187 | 0.291 | Hypoxia-inducible factor 1 alpha inhibitor | 0.238 0.111 DBMET01436 0.291 0.07 DBMET01437 0.241 0.109 DBMET03364 0.283 0.074 DBMET00507 | DBMET01437 | |
| 0.056 | 0.069 | 0.093 | Elastase 1 inhibitor | 0.093 0.025 DBMET01436 0.064 0.055 DBMET01437 | DBMET01436 | |
| 0.011 | 0.024 | 0.021 | Ileal bile acid transport inhibitor | 0.016 0.013 DBMET01437 0.021 0.008 DBMET00507 | DBMET00507 | |
| 0.026 | 0.039 | 0.038 | Dipeptidyl peptidase II inhibitor | 0.032 0.023 DBMET01436 0.031 0.024 DBMET01437 0.03 0.026 DB09157 0.038 0.016 DBMET03364 | DBMET03364 | |
| 0.024 | 0.038 | 0.033 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.033 0.021 DBMET01436 0.03 0.024 DBMET01437 0.033 0.021 DBMET03364 | DBMET03364 | |
| 0.01 | 0.025 | 0.015 | Cyclin D2 inhibitor | 0.014 0.007 DB09157 0.015 0.006 DBMET03364 | DBMET03364 | |
| 0.075 | 0.09 | 0.22 | Protein kinase (CK2) inhibitor | 0.149 0.033 DBMET01436 0.22 0.015 DBMET01437 | DBMET01437 | |
| 0.012 | 0.026 | 0.033 | Cyclin T1 inhibitor | 0.017 0.014 DBMET01436 0.02 0.011 DB09157 0.033 0.005 DBMET03364 | DBMET03364 | |
| 0.029 | 0.044 | 0.071 | Toll-Like receptor 2 agonist | 0.037 0.032 DBMET01436 0.037 0.032 DBMET01437 0.044 0.027 DB09157 0.038 0.031 DBMET03364 0.071 0.018 DBMET00507 | DBMET00507 | |
| 0.06 | 0.075 | 0.175 | Glutamate receptor agonist | 0.126 0.024 DBMET01436 0.175 0.013 DBMET01437 | DBMET01437 | |
| 0.022 | 0.038 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.019 DBMET03364 | DBMET03364 | |
| 0.026 | 0.042 | 0.12 | NMDA receptor subunit 3A antagonist | 0.048 0.021 DBMET01436 0.12 0.007 DBMET01437 0.063 0.016 DBMET03364 0.049 0.02 DBMET00507 | DBMET01437 | |
| 0.009 | 0.025 | 0.022 | G-protein-coupled receptor 120 agonist | 0.015 0.014 DBMET01436 0.022 0.008 DBMET01437 | DBMET01437 | |
| 0.011 | 0.027 | 0.03 | Alpha 2a adrenoreceptor agonist | 0.016 0.013 DBMET01436 0.018 0.011 DB09157 0.03 0.005 DBMET03364 | DBMET03364 | |
| 0.026 | 0.043 | 0.262 | Nicotinic acid receptor 2 agonist | 0.109 0.005 DBMET01436 0.262 0.003 DBMET01437 | DBMET01437 | |
| 0.034 | 0.051 | 0.1 | Antimetabolite | 0.051 0.031 DBMET01436 0.045 0.035 DBMET01437 0.1 0.016 DBMET00507 | DBMET00507 | |
| 0.044 | 0.061 | 0.073 | Nicotinic receptor alpha7 subunit antagonist | 0.057 0.032 DBMET01436 0.073 0.02 DBMET03364 | DBMET03364 | |
| 0.018 | 0.035 | 0.062 | AMPA 3 receptor antagonist | 0.034 0.017 DBMET01436 0.062 0.005 DBMET01437 0.05 0.009 DBMET00507 | DBMET01437 | |
| 0.188 | 0.205 | 0.483 | Sodium/bile acid cotransporter inhibitor | 0.297 0.082 DBMET01436 0.395 0.018 DBMET01437 0.483 0.005 DBMET00507 | DBMET00507 | |
| 0.077 | 0.095 | 0.099 | Protein kinase C zeta inhibitor | 0.098 0.053 DBMET01436 0.099 0.052 DBMET01437 0.082 0.081 DB09157 0.097 0.054 DBMET03364 | DBMET01437 | |
| 0.119 | 0.137 | 0.155 | MAP kinase 3 inhibitor | 0.141 0.082 DBMET01436 0.146 0.074 DBMET01437 0.136 0.092 DB09157 0.155 0.06 DBMET03364 | DBMET03364 | |
| 0.03 | 0.048 | 0.04 | Adenosine uptake inhibitor | 0.035 0.024 DBMET01436 0.037 0.017 DB09157 0.04 0.012 DBMET03364 | DBMET03364 | |
| 0.088 | 0.107 | 0.13 | Factor V inhibitor | 0.106 0.057 DBMET01436 0.13 0.03 DBMET01437 0.099 0.07 DBMET00507 | DBMET01437 | |
| 0.042 | 0.061 | 0.072 | Dopamine uptake inhibitor | 0.065 0.034 DBMET01436 0.072 0.029 DBMET03364 | DBMET03364 | |
| 0.014 | 0.033 | 0.031 | Alpha 2b adrenoreceptor agonist | 0.018 0.016 DBMET01436 0.018 0.016 DB09157 0.031 0.004 DBMET03364 | DBMET03364 | |
| 0.023 | 0.042 | 0.046 | Cholesterol ester transfer protein antagonist | 0.034 0.018 DBMET01436 0.046 0.009 DBMET01437 0.029 0.026 DBMET03364 | DBMET01437 | |
| 0.003 | 0.022 | 0.008 | Insulin like growth factor 3 antagonist | 0.008 0.003 DBMET01437 | DBMET01437 | |
| 0.057 | 0.077 | 0.118 | Epoxide hydrolase inhibitor | 0.08 0.042 DBMET01436 0.088 0.034 DBMET01437 0.069 0.055 DBMET03364 0.118 0.018 DBMET00507 | DBMET00507 | |
| 0.012 | 0.032 | 0.021 | Vitamin D receptor agonist | 0.021 0.006 DBMET00507 | DBMET00507 | |
| 0.051 | 0.072 | 0.086 | Corticotropin releasing factor 2 receptor antagonist | 0.065 0.036 DBMET01436 0.076 0.021 DB09157 0.086 0.013 DBMET03364 | DBMET03364 | |
| 0.051 | 0.071 | 0.066 | Phosphodiesterase 1A inhibitor | 0.062 0.036 DBMET01436 0.058 0.046 DBMET01437 0.059 0.044 DB09157 0.066 0.029 DBMET03364 | DBMET03364 | |
| 0.014 | 0.035 | 0.026 | Caspase 8 inhibitor | 0.021 0.011 DBMET01437 0.02 0.013 DBMET03364 0.026 0.007 DBMET00507 | DBMET00507 | |
| 0.023 | 0.044 | 0.031 | MAP3K8 inhibitor | 0.028 0.022 DBMET01436 0.031 0.017 DB09157 0.031 0.015 DBMET03364 | DBMET03364 | |
| 0.053 | 0.074 | 0.074 | Phosphodiesterase 1C inhibitor | 0.067 0.034 DBMET01436 0.074 0.024 DBMET01437 0.058 0.053 DB09157 0.067 0.034 DBMET03364 | DBMET01437 | |
| 0.006 | 0.028 | 0.035 | Integrin beta2 antagonist | 0.015 0.006 DBMET01437 0.035 0.004 DBMET00507 | DBMET00507 | |
| 0.031 | 0.053 | 0.058 | Oleamide hydrolase inhibitor | 0.058 0.022 DBMET01436 0.056 0.023 DBMET01437 0.041 0.037 DBMET03364 | DBMET01436 | |
| 0.086 | 0.108 | 0.15 | Proteasome inhibitor | 0.139 0.053 DBMET01436 0.106 0.079 DBMET01437 0.1 0.088 DB09157 0.145 0.049 DBMET03364 0.15 0.047 DBMET00507 | DBMET00507 | |
| 0.016 | 0.038 | 0.019 | Toll-Like receptor 8 agonist | 0.019 0.016 DBMET03364 | DBMET03364 | |
| 0.014 | 0.037 | 0.026 | Geranylgeranyltransferase inhibitor | 0.026 0.012 DBMET01436 0.02 0.018 DBMET01437 | DBMET01436 | |
| 0.032 | 0.055 | 0.045 | Nicotinic receptor alpha3 subunit antagonist | 0.043 0.032 DBMET01436 0.045 0.029 DBMET03364 | DBMET03364 | |
| 0.028 | 0.051 | 0.049 | Delayed rectifier potassium channel blocker | 0.037 0.026 DBMET01436 0.041 0.019 DB09157 0.049 0.012 DBMET03364 0.039 0.023 DBMET00507 | DBMET03364 | |
| 0.04 | 0.063 | 0.054 | 5 Hydroxytryptamine 4 antagonist | 0.053 0.033 DBMET01436 0.054 0.031 DBMET03364 | DBMET03364 | |
| 0.035 | 0.058 | 0.048 | Dihydrofolate reductase inhibitor | 0.045 0.027 DBMET01436 0.047 0.022 DBMET01437 0.04 0.039 DBMET03364 0.048 0.022 DBMET00507 | DBMET00507 | |
| 0.018 | 0.041 | 0.044 | Nicotinic alpha4beta2 receptor agonist | 0.027 0.021 DBMET01436 0.037 0.01 DB09157 0.044 0.006 DBMET03364 | DBMET03364 | |
| 0.056 | 0.08 | 0.096 | Calcium channel L-type blocker | 0.081 0.038 DBMET01436 0.096 0.026 DBMET01437 0.071 0.05 DBMET03364 | DBMET01437 | |
| 0.14 | 0.164 | 0.345 | Immunostimulant | 0.251 0.096 DBMET01436 0.274 0.087 DBMET01437 0.173 0.137 DB09157 0.204 0.118 DBMET03364 0.345 0.066 DBMET00507 | DBMET00507 | |
| 0.054 | 0.078 | 0.075 | Beta 3 adrenoreceptor antagonist | 0.064 0.044 DBMET01436 0.075 0.027 DBMET01437 0.06 0.056 DB09157 0.068 0.038 DBMET03364 0.064 0.046 DBMET00507 | DBMET01437 | |
| 0.027 | 0.052 | 0.059 | Glutamate (mGluR group II) antagonist | 0.04 0.024 DBMET01436 0.059 0.011 DBMET01437 | DBMET01437 | |
| 0.02 | 0.046 | 0.048 | Potassium channel small-conductance Ca-activated activator | 0.041 0.015 DB09157 0.048 0.012 DBMET03364 | DBMET03364 | |
| 0.02 | 0.047 | 0.027 | Thrombin receptor antagonist | 0.027 0.022 DBMET03364 | DBMET03364 | |
| 0.078 | 0.105 | 0.217 | Protein kinase (CK2) alpha inhibitor | 0.157 0.038 DBMET01436 0.217 0.021 DBMET01437 | DBMET01437 | |
| 0.105 | 0.132 | 0.221 | Acetylcholine M1 receptor antagonist | 0.153 0.072 DBMET01436 0.148 0.076 DBMET01437 0.221 0.034 DBMET03364 | DBMET03364 | |
| 0.008 | 0.036 | 0.035 | NMDA receptor phencyclidine site antagonist | 0.035 0.004 DBMET03364 | DBMET03364 | |
| 0.034 | 0.062 | 0.093 | Carbonic anhydrase I inhibitor | 0.091 0.021 DBMET01436 0.077 0.026 DBMET01437 0.093 0.02 DBMET00507 | DBMET00507 | |
| 0.026 | 0.053 | 0.044 | Ceramide glucosyltransferase inhibitor | 0.033 0.029 DBMET01436 0.035 0.027 DBMET01437 0.038 0.021 DB09157 0.041 0.016 DBMET03364 0.044 0.012 DBMET00507 | DBMET00507 | |
| 0.017 | 0.045 | 0.029 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.017 DBMET01436 0.025 0.02 DBMET01437 0.025 0.021 DB09157 0.029 0.014 DBMET03364 | DBMET03364 | |
| 0.008 | 0.036 | 0.014 | CXC chemokine 4 receptor agonist | 0.014 0.012 DBMET03364 | DBMET03364 | |
| 0.063 | 0.091 | 0.082 | Estrogen receptor alpha antagonist | 0.076 0.056 DBMET01436 0.08 0.049 DBMET01437 0.082 0.046 DBMET03364 | DBMET03364 | |
| 0.015 | 0.043 | 0.03 | Beta 1 adrenoreceptor agonist | 0.03 0.008 DBMET01437 | DBMET01437 | |
| 0.018 | 0.046 | 0.042 | Thyroid hormone agonist | 0.027 0.016 DBMET01437 0.042 0.005 DBMET00507 | DBMET00507 | |
| 0.019 | 0.048 | 0.045 | Peptide deformylase inhibitor | 0.03 0.021 DB09157 0.04 0.014 DBMET03364 0.045 0.012 DBMET00507 | DBMET00507 | |
| 0.008 | 0.037 | 0.193 | Prostaglandin EP1 antagonist | 0.193 0.004 DBMET01436 0.188 0.004 DBMET01437 | DBMET01436 | |
| 0.05 | 0.079 | 0.071 | Aryl hydrocarbon receptor antagonist | 0.065 0.045 DBMET01436 0.065 0.044 DB09157 0.071 0.037 DBMET03364 | DBMET03364 | |
| 0.011 | 0.04 | 0.017 | CDK2/cyclin A3 inhibitor | 0.017 0.01 DBMET03364 | DBMET03364 | |
| 0.044 | 0.074 | 0.067 | 5 Hydroxytryptamine 7 agonist | 0.055 0.042 DBMET01436 0.054 0.043 DB09157 0.067 0.022 DBMET03364 | DBMET03364 | |
| 0.007 | 0.036 | 0.012 | Melatonin 2 antagonist | 0.012 0.009 DBMET03364 | DBMET03364 | |
| 0.032 | 0.061 | 0.107 | AMPA receptor antagonist | 0.053 0.029 DBMET01436 0.107 0.01 DBMET01437 | DBMET01437 | |
| 0.054 | 0.084 | 0.069 | Beta 2 adrenoreceptor agonist | 0.061 0.045 DBMET01436 0.067 0.026 DBMET01437 0.059 0.054 DB09157 0.064 0.034 DBMET03364 0.069 0.02 DBMET00507 | DBMET00507 | |
| 0.012 | 0.042 | 0.079 | AMPA 1 receptor antagonist | 0.028 0.021 DBMET01436 0.079 0.007 DBMET01437 0.053 0.01 DBMET00507 | DBMET01437 | |
| 0.053 | 0.083 | 0.099 | Benzodiazepine agonist | 0.074 0.046 DBMET01436 0.099 0.026 DBMET03364 | DBMET03364 | |
| 0.007 | 0.038 | 0.049 | Peroxisome proliferator-activated receptor alpha antagonist | 0.049 0.008 DBMET01437 | DBMET01437 | |
| 0.03 | 0.06 | 0.102 | NMDA 2A receptor antagonist | 0.057 0.032 DBMET01436 0.1 0.013 DBMET01437 0.048 0.04 DBMET03364 0.102 0.013 DBMET00507 | DBMET00507 | |
| 0.041 | 0.072 | 0.101 | Factor III inhibitor | 0.052 0.029 DBMET01436 0.101 0.005 DBMET01437 0.071 0.01 DBMET00507 | DBMET01437 | |
| 0.044 | 0.075 | 0.069 | Cyclin D1 inhibitor | 0.062 0.039 DBMET01436 0.064 0.036 DB09157 0.069 0.03 DBMET03364 | DBMET03364 | |
| 0.036 | 0.067 | 0.104 | Diacylglycerol O-acyltransferase inhibitor | 0.053 0.032 DBMET01436 0.089 0.01 DBMET01437 0.104 0.006 DBMET00507 | DBMET00507 | |
| 0.018 | 0.05 | 0.028 | Sodium/glucose cotransporter inhibitor | 0.026 0.018 DBMET01436 0.024 0.021 DBMET01437 0.024 0.023 DB09157 0.028 0.013 DBMET03364 | DBMET03364 | |
| 0.03 | 0.061 | 0.058 | 5 Hydroxytryptamine 2B agonist | 0.037 0.031 DBMET01436 0.038 0.028 DB09157 0.058 0.009 DBMET03364 | DBMET03364 | |
| 0.046 | 0.077 | 0.071 | Sphingosine kinase inhibitor | 0.059 0.041 DBMET01436 0.062 0.035 DBMET01437 0.06 0.038 DB09157 0.071 0.023 DBMET03364 0.054 0.05 DBMET00507 | DBMET03364 | |
| 0.027 | 0.059 | 0.082 | Purinergic P2Y antagonist | 0.062 0.019 DBMET01436 0.082 0.012 DBMET01437 0.042 0.034 DBMET00507 | DBMET01437 | |
| 0.069 | 0.101 | 0.117 | Transcription factor NF kappa B stimulant | 0.096 0.043 DBMET01436 0.117 0.027 DBMET01437 | DBMET01437 | |
| 0.131 | 0.163 | 0.188 | Focal adhesion kinase 2 inhibitor | 0.174 0.095 DBMET01436 0.163 0.11 DBMET01437 0.15 0.131 DB09157 0.188 0.079 DBMET03364 | DBMET03364 | |
| 0.064 | 0.096 | 0.11 | Sphingosine 1-phosphate receptor antagonist | 0.081 0.043 DBMET01436 0.102 0.02 DBMET01437 0.11 0.016 DBMET00507 | DBMET00507 | |
| 0.021 | 0.053 | 0.041 | Liver X receptor beta agonist | 0.032 0.024 DBMET01436 0.041 0.014 DBMET01437 | DBMET01437 | |
| 0.02 | 0.053 | 0.034 | 5 Hydroxytryptamine 6 agonist | 0.027 0.023 DB09157 0.034 0.011 DBMET03364 | DBMET03364 | |
| 0.009 | 0.042 | 0.028 | Nicotinic alpha4 receptor agonist | 0.016 0.011 DB09157 0.028 0.005 DBMET03364 | DBMET03364 | |
| 0.027 | 0.059 | 0.043 | Protein kinase C beta I inhibitor | 0.036 0.017 DBMET01436 0.043 0.006 DBMET01437 | DBMET01437 | |
| 0.037 | 0.07 | 0.082 | Glutamate (mGluR1) antagonist | 0.07 0.03 DBMET01436 0.082 0.023 DBMET01437 0.071 0.03 DBMET03364 0.05 0.048 DBMET00507 | DBMET01437 | |
| 0.004 | 0.037 | 0.011 | Thyroid hormone beta agonist | 0.011 0.005 DBMET00507 | DBMET00507 | |
| 0.019 | 0.053 | 0.035 | Glutamate (mGluR2) antagonist | 0.027 0.025 DBMET01436 0.035 0.014 DBMET01437 | DBMET01437 | |
| 0.01 | 0.044 | 0.023 | Alpha 2c adrenoreceptor agonist | 0.023 0.008 DBMET03364 | DBMET03364 | |
| 0.052 | 0.086 | 0.097 | Acetylcholine M4 receptor antagonist | 0.078 0.048 DBMET01436 0.097 0.03 DBMET03364 | DBMET03364 | |
| 0.033 | 0.069 | 0.053 | CC chemokine 4 receptor antagonist | 0.046 0.034 DBMET01436 0.048 0.031 DB09157 0.053 0.023 DBMET03364 | DBMET03364 | |
| 0.029 | 0.065 | 0.081 | Ribonucleoside-diphosphate reductase inhibitor | 0.05 0.04 DBMET01437 0.047 0.043 DBMET03364 0.081 0.024 DBMET00507 | DBMET00507 | |
| 0.044 | 0.08 | 0.081 | Sphingosine 1-phosphate receptor 1 antagonist | 0.056 0.037 DBMET01436 0.07 0.018 DBMET01437 0.081 0.014 DBMET00507 | DBMET00507 | |
| 0.019 | 0.055 | 0.028 | Myristoyl transferase inhibitor | 0.028 0.018 DBMET03364 | DBMET03364 | |
| 0.027 | 0.065 | 0.097 | Peroxisome proliferator-activated receptor alpha agonist | 0.051 0.031 DBMET01436 0.097 0.013 DBMET01437 0.062 0.025 DBMET00507 | DBMET01437 | |
| 0.041 | 0.079 | 0.069 | Glucosylceramidase inhibitor | 0.054 0.04 DBMET01436 0.061 0.03 DBMET01437 0.056 0.036 DB09157 0.069 0.023 DBMET03364 | DBMET03364 | |
| 0.029 | 0.067 | 0.084 | Ribonucleotide reductase inhibitor | 0.051 0.042 DBMET01437 0.047 0.044 DBMET03364 0.084 0.025 DBMET00507 | DBMET00507 | |
| 0.023 | 0.061 | 0.046 | Estradiol 17 beta-dehydrogenase inhibitor | 0.046 0.027 DBMET01437 | DBMET01437 | |
| 0.031 | 0.07 | 0.086 | Carbonic anhydrase II inhibitor | 0.086 0.023 DBMET01436 0.069 0.03 DBMET01437 0.085 0.023 DBMET00507 | DBMET01436 | |
| 0.064 | 0.102 | 0.092 | GABA A receptor agonist | 0.088 0.051 DBMET01436 0.092 0.046 DBMET03364 | DBMET03364 | |
| 0.037 | 0.076 | 0.108 | Carbonic anhydrase inhibitor | 0.108 0.024 DBMET01436 0.089 0.031 DBMET01437 0.103 0.026 DBMET00507 | DBMET01436 | |
| 0.014 | 0.054 | 0.028 | CXC chemokine 2 receptor antagonist | 0.028 0.017 DBMET01437 0.027 0.017 DBMET03364 | DBMET01437 | |
| 0.045 | 0.086 | 0.138 | Prostaglandin F2 alpha antagonist | 0.134 0.005 DBMET01436 0.138 0.005 DBMET01437 0.058 0.051 DBMET00507 | DBMET01437 | |
| 0.039 | 0.081 | 0.068 | TRPA1 antagonist | 0.068 0.035 DBMET01436 0.054 0.052 DBMET01437 0.055 0.05 DBMET03364 | DBMET01436 | |
| 0.055 | 0.097 | 0.103 | Acetylcholine nicotinic antagonist | 0.081 0.053 DBMET01436 0.103 0.037 DBMET03364 | DBMET03364 | |
| 0.017 | 0.059 | 0.044 | Peroxisome proliferator-activated receptor delta agonist | 0.044 0.015 DBMET01437 0.031 0.026 DBMET00507 | DBMET01437 | |
| 0.047 | 0.089 | 0.06 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.06 0.043 DBMET01436 0.057 0.051 DBMET01437 0.06 0.044 DBMET03364 | DBMET03364 | |
| 0.11 | 0.153 | 0.153 | LIM domain kinase 1 inhibitor | 0.153 0.095 DBMET01436 0.139 0.11 DBMET01437 0.146 0.102 DBMET03364 | DBMET01436 | |
| 0.03 | 0.073 | 0.043 | Microtubule stabilization | 0.043 0.037 DBMET01436 0.042 0.038 DBMET01437 | DBMET01436 | |
| 0.007 | 0.05 | 0.02 | Integrin alphaVbeta6 antagonist | 0.02 0.006 DBMET00507 | DBMET00507 | |
| 0.037 | 0.08 | 0.052 | Beta adrenoreceptor agonist | 0.046 0.027 DBMET01436 0.052 0.015 DBMET01437 0.047 0.025 DBMET00507 | DBMET01437 | |
| 0.028 | 0.072 | 0.067 | Sphingosine 1-phosphate receptor agonist | 0.046 0.029 DBMET01436 0.067 0.013 DBMET01437 0.062 0.015 DBMET00507 | DBMET01437 | |
| 0.026 | 0.07 | 0.053 | Sphingosine 1-phosphate receptor 1 agonist | 0.043 0.028 DBMET01436 0.053 0.017 DBMET01437 0.05 0.02 DBMET00507 | DBMET01437 | |
| 0.003 | 0.047 | 0.014 | Integrin alphaVbeta5 antagonist | 0.014 0.005 DBMET00507 | DBMET00507 | |
| 0.106 | 0.15 | 0.225 | Hemostatic | 0.153 0.064 DBMET01436 0.213 0.028 DBMET01437 0.128 0.1 DBMET03364 0.225 0.025 DBMET00507 | DBMET00507 | |
| 0.03 | 0.075 | 0.121 | Neuraminidase (Influenza A) inhibitor | 0.072 0.006 DBMET01436 0.121 0.004 DBMET01437 | DBMET01437 | |
| 0.043 | 0.088 | 0.079 | 5 Hydroxytryptamine 3A antagonist | 0.066 0.047 DBMET01436 0.079 0.032 DBMET03364 | DBMET03364 | |
| 0.027 | 0.073 | 0.042 | Histone deacetylase 9 inhibitor | 0.041 0.024 DBMET03364 0.042 0.023 DBMET00507 | DBMET00507 | |
| 0.017 | 0.062 | 0.026 | 5 Hydroxytryptamine 4 agonist | 0.026 0.013 DBMET03364 | DBMET03364 | |
| 0.072 | 0.117 | 0.128 | Nitric-oxide synthase inhibitor | 0.097 0.065 DBMET01436 0.128 0.034 DBMET03364 | DBMET03364 | |
| 0.071 | 0.117 | 0.13 | MAP kinase kinase 1 inhibitor | 0.1 0.057 DBMET01436 0.121 0.034 DBMET01437 0.101 0.055 DB09157 0.13 0.027 DBMET03364 | DBMET03364 | |
| 0.022 | 0.068 | 0.042 | Histone deacetylase 7 inhibitor | 0.038 0.025 DBMET03364 0.042 0.022 DBMET00507 | DBMET00507 | |
| 0.039 | 0.086 | 0.077 | Collagenase 3 inhibitor | 0.07 0.032 DBMET01436 0.077 0.027 DBMET01437 0.067 0.034 DBMET00507 | DBMET01437 | |
| 0.074 | 0.12 | 0.121 | GABA receptor agonist | 0.119 0.057 DBMET01436 0.104 0.073 DBMET01437 0.121 0.055 DBMET03364 | DBMET03364 | |
| 0.034 | 0.081 | 0.067 | Beta 1 adrenoreceptor antagonist | 0.051 0.045 DBMET01436 0.06 0.035 DBMET01437 0.059 0.036 DBMET03364 0.067 0.029 DBMET00507 | DBMET00507 | |
| 0.054 | 0.101 | 0.08 | Adenosine A3 receptor antagonist | 0.08 0.044 DBMET01436 0.068 0.062 DBMET01437 0.07 0.058 DBMET03364 | DBMET01436 | |
| 0.045 | 0.092 | 0.113 | Prostaglandin-E synthase inhibitor | 0.072 0.047 DBMET01436 0.113 0.021 DBMET01437 0.072 0.047 DBMET00507 | DBMET01437 | |
| 0.016 | 0.063 | 0.028 | CDK4/cyclin D3 inhibitor | 0.028 0.02 DBMET03364 | DBMET03364 | |
| 0.062 | 0.11 | 0.089 | Histamine H2 receptor antagonist | 0.082 0.061 DBMET01436 0.083 0.058 DBMET01437 0.076 0.074 DB09157 0.089 0.048 DBMET03364 | DBMET03364 | |
| 0.025 | 0.073 | 0.041 | MAP3K5 inhibitor | 0.037 0.03 DB09157 0.041 0.023 DBMET03364 | DBMET03364 | |
| 0.041 | 0.09 | 0.102 | DNA helicase inhibitor | 0.057 0.033 DBMET01436 0.088 0.008 DBMET01437 0.102 0.005 DBMET00507 | DBMET00507 | |
| 0.066 | 0.118 | 0.123 | Gastric antisecretory | 0.123 0.041 DBMET01436 0.117 0.046 DBMET01437 0.09 0.079 DBMET03364 | DBMET01436 | |
| 0.035 | 0.087 | 0.064 | Acetylcholine M3 receptor antagonist | 0.055 0.048 DBMET01436 0.064 0.037 DBMET03364 | DBMET03364 | |
| 0.031 | 0.084 | 0.107 | Carnitine palmitoyltransferase 1B inhibitor | 0.049 0.03 DBMET01436 0.107 0.005 DBMET01437 0.049 0.031 DBMET00507 | DBMET01437 | |
| 0.042 | 0.094 | 0.085 | Neuronal nicotinic receptor antagonist | 0.064 0.051 DBMET01436 0.085 0.032 DBMET03364 | DBMET03364 | |
| 0.028 | 0.081 | 0.075 | Aromatase inhibitor | 0.05 0.048 DBMET01436 0.075 0.03 DBMET03364 | DBMET03364 | |
| 0.004 | 0.057 | 0.01 | Beta 3 adrenoreceptor agonist | 0.01 0.009 DBMET01437 | DBMET01437 | |
| 0.021 | 0.074 | 0.048 | Purinergic P2Y2 antagonist | 0.03 0.029 DBMET01436 0.048 0.011 DBMET01437 | DBMET01437 | |
| 0.02 | 0.074 | 0.073 | Carbonic anhydrase XII inhibitor | 0.047 0.04 DBMET01436 0.073 0.028 DBMET01437 | DBMET01437 | |
| 0.037 | 0.092 | 0.067 | Acetylcholine M5 receptor antagonist | 0.054 0.052 DBMET01436 0.067 0.034 DBMET03364 | DBMET03364 | |
| 0.06 | 0.115 | 0.171 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.101 0.037 DBMET01436 0.171 0.01 DBMET01437 | DBMET01437 | |
| 0.027 | 0.082 | 0.047 | Sphingosine kinase 1 inhibitor | 0.039 0.032 DB09157 0.047 0.02 DBMET03364 | DBMET03364 | |
| 0.02 | 0.076 | 0.071 | Carbonic anhydrase IX inhibitor | 0.051 0.042 DBMET01436 0.071 0.032 DBMET01437 | DBMET01437 | |
| 0.03 | 0.086 | 0.247 | Prostaglandin EP2 antagonist | 0.088 0.023 DBMET01436 0.247 0.005 DBMET01437 0.092 0.021 DBMET00507 | DBMET01437 | |
| 0.013 | 0.07 | 0.037 | Endothelial nitric-oxide synthase inhibitor | 0.037 0.016 DBMET03364 | DBMET03364 | |
| 0.042 | 0.1 | 0.081 | Beta adrenoreceptor antagonist | 0.06 0.055 DBMET01436 0.07 0.039 DBMET01437 0.067 0.043 DBMET03364 0.081 0.026 DBMET00507 | DBMET00507 | |
| 0.029 | 0.086 | 0.064 | Beta 2 adrenoreceptor antagonist | 0.05 0.036 DBMET01437 0.049 0.039 DBMET03364 0.064 0.021 DBMET00507 | DBMET00507 | |
| 0.011 | 0.069 | 0.088 | Leukotriene B4 receptor 2 antagonist | 0.088 0.003 DBMET01436 0.046 0.005 DBMET01437 | DBMET01436 | |
| 0.012 | 0.07 | 0.062 | Acetylcholine M4 receptor agonist | 0.03 0.022 DB09157 0.062 0.009 DBMET03364 | DBMET03364 | |
| 0.029 | 0.087 | 0.063 | Potassium channel small-conductance Ca-activated blocker | 0.063 0.016 DBMET03364 | DBMET03364 | |
| 0.067 | 0.125 | 0.113 | Thioredoxin inhibitor | 0.113 0.035 DBMET01436 0.087 0.067 DBMET01437 | DBMET01436 | |
| 0.035 | 0.094 | 0.082 | Neutrophil collagenase inhibitor | 0.063 0.047 DBMET01437 0.082 0.03 DBMET00507 | DBMET00507 | |
| 0.068 | 0.127 | 0.11 | 3C-Like protease (SARS coronavirus) inhibitor | 0.091 0.045 DBMET01436 0.11 0.025 DBMET01437 | DBMET01437 | |
| 0.01 | 0.071 | 0.084 | Leukotriene B4 receptor 1 antagonist | 0.084 0.004 DBMET01436 0.066 0.005 DBMET01437 | DBMET01436 | |
| 0.025 | 0.086 | 0.049 | Metalloproteinase-3 inhibitor | 0.049 0.034 DBMET00507 | DBMET00507 | |
| 0.022 | 0.083 | 0.037 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.037 0.025 DBMET03364 | DBMET03364 | |
| 0.045 | 0.109 | 0.07 | Potassium channel (ATP-sensitive) blocker | 0.062 0.055 DBMET01436 0.07 0.04 DBMET03364 | DBMET03364 | |
| 0.033 | 0.097 | 0.054 | Matrix metalloproteinase (membrane-type) inhibitor | 0.054 0.039 DBMET00507 | DBMET00507 | |
| 0.078 | 0.142 | 0.115 | Calcium channel N-type blocker | 0.111 0.077 DBMET01436 0.102 0.091 DBMET01437 0.115 0.07 DBMET03364 | DBMET03364 | |
| 0.026 | 0.091 | 0.355 | Prostaglandin E2 antagonist | 0.27 0.005 DBMET01436 0.355 0.004 DBMET01437 | DBMET01437 | |
| 0.032 | 0.098 | 0.042 | Dipeptidyl peptidase IV inhibitor | 0.042 0.036 DBMET03364 | DBMET03364 | |
| 0.02 | 0.085 | 0.042 | Factor XIIIa inhibitor | 0.042 0.021 DBMET00507 | DBMET00507 | |
| 0.007 | 0.073 | 0.011 | CD80 antagonist | 0.011 0.009 DBMET01437 | DBMET01437 | |
| 0.099 | 0.165 | 0.288 | NOS3 expression enhancer | 0.193 0.044 DBMET01436 0.288 0.02 DBMET01437 | DBMET01437 | |
| 0.071 | 0.138 | 0.161 | Acetylcholine muscarinic antagonist | 0.11 0.078 DBMET01436 0.102 0.089 DBMET01437 0.161 0.038 DBMET03364 | DBMET03364 | |
| 0.018 | 0.086 | 0.046 | Vascular adhesion protein 1 inhibitor | 0.037 0.03 DB09157 0.046 0.019 DBMET03364 | DBMET03364 | |
| 0.038 | 0.107 | 0.063 | Phosphodiesterase 1B inhibitor | 0.054 0.052 DBMET01437 0.063 0.038 DBMET03364 | DBMET03364 | |
| 0.049 | 0.118 | 0.074 | Bcr-Abl kinase inhibitor | 0.074 0.072 DBMET01436 | DBMET01436 | |
| 0.027 | 0.099 | 0.055 | Cathepsin L inhibitor | 0.055 0.045 DBMET03364 0.055 0.044 DBMET00507 | DBMET00507 | |
| 0.011 | 0.084 | 0.02 | Glutaminyl-peptide cyclotransferase inhibitor | 0.02 0.019 DBMET03364 | DBMET03364 | |
| 0.077 | 0.151 | 0.131 | Cytokine production inhibitor | 0.114 0.095 DBMET01436 0.116 0.094 DBMET01437 0.131 0.079 DBMET03364 | DBMET03364 | |
| 0.141 | 0.215 | 0.276 | Lipoxygenase inhibitor | 0.271 0.086 DBMET01436 0.276 0.084 DBMET01437 0.223 0.12 DBMET03364 | DBMET01437 | |
| 0.031 | 0.106 | 0.049 | Histamine H4 receptor antagonist | 0.049 0.032 DBMET03364 | DBMET03364 | |
| 0.05 | 0.125 | 0.172 | NMDA receptor antagonist | 0.084 0.06 DBMET01436 0.172 0.019 DBMET01437 0.09 0.054 DBMET03364 0.091 0.053 DBMET00507 | DBMET01437 | |
| 0.04 | 0.115 | 0.073 | Heat shock protein 90 beta antagonist | 0.055 0.048 DBMET01437 0.073 0.026 DBMET03364 0.061 0.038 DBMET00507 | DBMET03364 | |
| 0.035 | 0.111 | 0.05 | Dipeptidyl peptidase inhibitor | 0.05 0.043 DBMET03364 | DBMET03364 | |
| 0.018 | 0.093 | 0.043 | DNA gyrase subunit B inhibitor | 0.043 0.019 DBMET01437 0.038 0.027 DBMET00507 | DBMET01437 | |
| 0.053 | 0.129 | 0.078 | Orexin receptor 1 antagonist | 0.067 0.066 DB09157 0.078 0.038 DBMET03364 | DBMET03364 | |
| 0.104 | 0.18 | 0.241 | MAP kinase kinase 2 inhibitor | 0.168 0.106 DBMET01436 0.183 0.093 DBMET01437 0.166 0.107 DB09157 0.241 0.058 DBMET03364 0.151 0.121 DBMET00507 | DBMET03364 | |
| 0.051 | 0.127 | 0.068 | Phosphodiesterase VI inhibitor | 0.068 0.067 DBMET01436 | DBMET01436 | |
| 0.004 | 0.08 | 0.025 | Integrin alpha4beta1 antagonist | 0.025 0.008 DBMET00507 | DBMET00507 | |
| 0.044 | 0.12 | 0.243 | Potassium channel large-conductance Ca-activated activator | 0.096 0.025 DBMET01436 0.243 0.005 DBMET01437 0.073 0.041 DBMET00507 | DBMET01437 | |
| 0.033 | 0.11 | 0.067 | Glucose-6-phosphate translocase inhibitor | 0.049 0.04 DBMET01436 0.067 0.017 DBMET01437 | DBMET01437 | |
| 0.015 | 0.092 | 0.033 | AMPA receptor agonist | 0.033 0.029 DBMET01437 | DBMET01437 | |
| 0.032 | 0.109 | 0.132 | NMDA 2 receptor antagonist | 0.07 0.052 DBMET01436 0.132 0.021 DBMET01437 0.071 0.05 DBMET00507 | DBMET01437 | |
| 0.019 | 0.097 | 0.291 | Glycine transporter 2 inhibitor | 0.291 0.004 DBMET00507 | DBMET00507 | |
| 0.06 | 0.138 | 0.089 | Phosphodiesterase I inhibitor | 0.082 0.072 DBMET01436 0.084 0.069 DBMET01437 0.089 0.06 DBMET03364 | DBMET03364 | |
| 0.098 | 0.178 | 0.175 | Heat shock protein 90 alpha antagonist | 0.15 0.087 DBMET01436 0.175 0.066 DBMET01437 0.132 0.108 DBMET03364 | DBMET01437 | |
| 0.046 | 0.127 | 0.114 | Metalloproteinase-2 inhibitor | 0.07 0.066 DBMET01437 0.069 0.068 DBMET03364 0.114 0.032 DBMET00507 | DBMET00507 | |
| 0.031 | 0.112 | 0.077 | Cyclin-dependent kinase 6 inhibitor | 0.061 0.04 DB09157 0.077 0.024 DBMET03364 | DBMET03364 | |
| 0.003 | 0.085 | 0.014 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.014 0.011 DBMET01437 | DBMET01437 | |
| 0.064 | 0.145 | 0.105 | Potassium channel (Voltage-sensitive) activator | 0.105 0.048 DBMET03364 | DBMET03364 | |
| 0.027 | 0.109 | 0.065 | GABA receptor antagonist | 0.065 0.028 DBMET01436 | DBMET01436 | |
| 0.008 | 0.09 | 0.027 | 5 Hydroxytryptamine 1D agonist | 0.027 0.021 DBMET03364 | DBMET03364 | |
| 0.034 | 0.117 | 0.059 | CDC7 inhibitor | 0.059 0.058 DBMET03364 | DBMET03364 | |
| 0.03 | 0.113 | 0.084 | 5 Hydroxytryptamine 2A agonist | 0.084 0.024 DBMET03364 | DBMET03364 | |
| 0.046 | 0.129 | 0.113 | Androgen antagonist | 0.102 0.045 DBMET01436 0.086 0.059 DBMET01437 0.113 0.037 DBMET03364 | DBMET03364 | |
| 0.045 | 0.128 | 0.086 | Secretase beta inhibitor | 0.065 0.059 DBMET01436 0.065 0.058 DB09157 0.086 0.029 DBMET03364 | DBMET03364 | |
| 0.038 | 0.123 | 0.083 | Amidase inhibitor | 0.083 0.035 DBMET01436 0.064 0.058 DBMET00507 | DBMET01436 | |
| 0.064 | 0.149 | 0.213 | DNA polymerase I inhibitor | 0.125 0.064 DBMET01436 0.213 0.024 DBMET01437 0.125 0.065 DBMET00507 | DBMET01437 | |
| 0.047 | 0.133 | 0.117 | Adrenaline agonist | 0.091 0.045 DBMET01436 0.117 0.027 DBMET01437 0.075 0.065 DBMET03364 0.088 0.047 DBMET00507 | DBMET01437 | |
| 0.005 | 0.09 | 0.027 | Angiotensin AT1A receptor antagonist | 0.027 0.008 DBMET01437 | DBMET01437 | |
| 0.029 | 0.115 | 0.056 | Lysine-specific demethylase 1A inhibitor | 0.056 0.034 DBMET03364 | DBMET03364 | |
| 0.034 | 0.12 | 0.191 | HIV-1 integrase (3'-Processing) inhibitor | 0.059 0.048 DBMET01436 0.191 0.01 DBMET01437 | DBMET01437 | |
| 0.103 | 0.189 | 0.17 | Tumour necrosis factor antagonist | 0.159 0.089 DBMET01436 0.159 0.089 DBMET01437 0.17 0.077 DBMET03364 | DBMET03364 | |
| 0.007 | 0.093 | 0.077 | Somatostatin 5 antagonist | 0.077 0.008 DBMET01437 | DBMET01437 | |
| 0.026 | 0.114 | 0.053 | Potassium channel (Inward rectifier) blocker | 0.053 0.03 DBMET03364 | DBMET03364 | |
| 0.012 | 0.099 | 0.035 | Cathepsin L1 inhibitor | 0.035 0.032 DBMET03364 | DBMET03364 | |
| 0.029 | 0.117 | 0.054 | Cyclin A1 inhibitor | 0.054 0.053 DBMET03364 0.054 0.053 DBMET00507 | DBMET00507 | |
| 0.028 | 0.117 | 0.055 | CC chemokine 2 receptor antagonist | 0.055 0.038 DBMET01436 0.052 0.042 DBMET01437 0.05 0.044 DBMET00507 | DBMET01436 | |
| 0.016 | 0.105 | 0.066 | Acetylcholine M1 receptor agonist | 0.066 0.02 DBMET03364 | DBMET03364 | |
| 0.033 | 0.123 | 0.057 | Acetyl-CoA transferase 2 inhibitor | 0.057 0.039 DBMET01436 | DBMET01436 | |
| 0.009 | 0.099 | 0.148 | Glucagon receptor antagonist | 0.148 0.004 DBMET00507 | DBMET00507 | |
| 0.023 | 0.114 | 0.076 | Acetylcholine muscarinic agonist | 0.076 0.024 DBMET03364 | DBMET03364 | |
| 0.053 | 0.145 | 0.091 | Potassium channel activator | 0.084 0.069 DBMET01436 0.086 0.067 DBMET01437 0.091 0.059 DBMET03364 | DBMET03364 | |
| 0.045 | 0.139 | 0.077 | Metalloproteinase-9 inhibitor | 0.068 0.06 DBMET03364 0.077 0.046 DBMET00507 | DBMET00507 | |
| 0.044 | 0.139 | 0.086 | MAO A inhibitor | 0.086 0.074 DBMET03364 | DBMET03364 | |
| 0.024 | 0.12 | 0.121 | Maillard reaction inhibitor | 0.053 0.04 DBMET01436 0.121 0.01 DBMET01437 | DBMET01437 | |
| 0.055 | 0.152 | 0.369 | Uric acid excretion stimulant | 0.275 0.005 DBMET01436 0.369 0.004 DBMET01437 | DBMET01437 | |
| 0.065 | 0.164 | 0.16 | Cholinergic antagonist | 0.101 0.095 DBMET01436 0.16 0.047 DBMET03364 | DBMET03364 | |
| 0.035 | 0.134 | 0.128 | CDC25B inhibitor | 0.069 0.038 DBMET01436 0.128 0.009 DBMET01437 | DBMET01437 | |
| 0.004 | 0.103 | 0.053 | Egl nine homolog 2 inhibitor | 0.012 0.009 DBMET01437 0.053 0.004 DBMET00507 | DBMET00507 | |
| 0.019 | 0.118 | 0.047 | Matrix metalloproteinase 1 inhibitor | 0.047 0.041 DBMET00507 | DBMET00507 | |
| 0.031 | 0.13 | 0.072 | Matrix metalloproteinase inhibitor | 0.072 0.042 DBMET00507 | DBMET00507 | |
| 0.064 | 0.164 | 0.156 | Acetylcholine antagonist | 0.098 0.095 DBMET01436 0.156 0.047 DBMET03364 | DBMET03364 | |
| 0.019 | 0.119 | 0.09 | Stearoyl-CoA desaturase inhibitor | 0.09 0.009 DBMET00507 | DBMET00507 | |
| 0.029 | 0.131 | 0.09 | Alpha 2 adrenoreceptor agonist | 0.09 0.018 DBMET03364 | DBMET03364 | |
| 0.038 | 0.14 | 0.061 | 5 Hydroxytryptamine 5A antagonist | 0.061 0.044 DBMET03364 | DBMET03364 | |
| 0.058 | 0.162 | 0.083 | Polo-like kinase-1 inhibitor | 0.082 0.079 DBMET01437 0.083 0.077 DBMET03364 | DBMET03364 | |
| 0.02 | 0.124 | 0.066 | Adenosine A1 receptor antagonist | 0.066 0.035 DBMET03364 | DBMET03364 | |
| 0.01 | 0.115 | 0.046 | Prostaglandin D2 agonist | 0.046 0.009 DBMET01437 | DBMET01437 | |
| 0.042 | 0.147 | 0.104 | Acetylcholine nicotinic agonist | 0.104 0.034 DBMET03364 | DBMET03364 | |
| 0.025 | 0.131 | 0.055 | Histamine agonist | 0.055 0.033 DBMET03364 | DBMET03364 | |
| 0.022 | 0.128 | 0.205 | Plasminogen activator inhibitor antagonist | 0.163 0.005 DBMET01436 0.205 0.004 DBMET01437 0.058 0.025 DBMET00507 | DBMET01437 | |
| 0.008 | 0.118 | 0.128 | Leukotriene A4 hydrolase inhibitor | 0.04 0.025 DBMET01436 0.128 0.005 DBMET01437 | DBMET01437 | |
| 0.006 | 0.117 | 0.082 | Kainate receptor 5 antagonist | 0.082 0.004 DBMET01437 | DBMET01437 | |
| 0.026 | 0.138 | 0.124 | Protein kinase C eta inhibitor | 0.06 0.034 DBMET01436 0.124 0.011 DBMET01437 | DBMET01437 | |
| 0.033 | 0.147 | 0.055 | 5 Hydroxytryptamine 5 antagonist | 0.055 0.046 DBMET03364 | DBMET03364 | |
| 0.12 | 0.235 | 0.244 | Prostaglandin dehydrogenase inhibitor | 0.222 0.143 DBMET01436 0.244 0.13 DBMET01437 0.177 0.175 DBMET03364 | DBMET01437 | |
| 0.034 | 0.15 | 0.06 | I kappa B kinase 2 inhibitor | 0.06 0.046 DBMET01436 | DBMET01436 | |
| 0.032 | 0.148 | 0.217 | Neuraminidase (influenza) inhibitor | 0.115 0.013 DBMET01436 0.217 0.004 DBMET01437 | DBMET01437 | |
| 0.006 | 0.123 | 0.016 | Angiotensin-converting enzyme 2 inhibitor | 0.016 0.015 DBMET00507 | DBMET00507 | |
| 0.072 | 0.189 | 0.112 | Calcium channel blocker | 0.112 0.097 DBMET01436 0.109 0.1 DBMET01437 | DBMET01436 | |
| 0.063 | 0.181 | 0.108 | Toll-Like receptor 4 antagonist | 0.108 0.057 DBMET01436 0.106 0.06 DBMET01437 | DBMET01436 | |
| 0.023 | 0.141 | 0.18 | HIV-1 integrase (Strand Transfer) inhibitor | 0.18 0.011 DBMET01437 | DBMET01437 | |
| 0.038 | 0.156 | 0.066 | Orexin receptor antagonist | 0.066 0.047 DBMET03364 | DBMET03364 | |
| 0.098 | 0.217 | 0.203 | Antipruritic | 0.203 0.047 DBMET01436 0.186 0.059 DBMET01437 0.135 0.114 DBMET03364 | DBMET01436 | |
| 0.085 | 0.205 | 0.154 | Cyclin-dependent kinase 8 inhibitor | 0.125 0.11 DB09157 0.154 0.076 DBMET03364 | DBMET03364 | |
| 0.025 | 0.145 | 0.062 | Nicotinic alpha7 receptor agonist | 0.062 0.03 DBMET03364 | DBMET03364 | |
| 0.03 | 0.15 | 0.066 | Dopamine D1 antagonist | 0.066 0.043 DBMET03364 | DBMET03364 | |
| 0.02 | 0.141 | 0.057 | 5 Hydroxytryptamine 2 agonist | 0.057 0.03 DBMET03364 | DBMET03364 | |
| 0.032 | 0.152 | 0.075 | Histamine H1 receptor antagonist | 0.075 0.062 DBMET01436 0.075 0.062 DBMET01437 | DBMET01437 | |
| 0.047 | 0.168 | 0.083 | Chymotrypsin inhibitor | 0.075 0.062 DBMET01436 0.081 0.053 DBMET01437 0.083 0.051 DBMET00507 | DBMET00507 | |
| 0.059 | 0.18 | 0.151 | Beta amyloid protein antagonist | 0.151 0.04 DBMET01436 0.098 0.092 DBMET01437 0.115 0.073 DBMET03364 | DBMET01436 | |
| 0.045 | 0.169 | 0.08 | Pim-3 kinase inhibitor | 0.08 0.077 DBMET03364 | DBMET03364 | |
| 0.052 | 0.176 | 0.082 | Factor XII inhibitor | 0.082 0.062 DBMET01436 | DBMET01436 | |
| 0.019 | 0.143 | 0.066 | Cannabinoid CB1 receptor agonist | 0.066 0.038 DBMET00507 | DBMET00507 | |
| 0.039 | 0.164 | 0.105 | CDC25A inhibitor | 0.066 0.063 DBMET01436 0.105 0.025 DBMET01437 | DBMET01437 | |
| 0.088 | 0.213 | 0.35 | Nitric oxide antagonist | 0.149 0.096 DBMET01437 0.35 0.032 DBMET03364 | DBMET03364 | |
| 0.009 | 0.134 | 0.048 | Carnitine palmitoyltransferase 1A inhibitor | 0.035 0.012 DBMET01436 0.048 0.008 DBMET01437 | DBMET01437 | |
| 0.015 | 0.141 | 0.065 | Peroxisome proliferator-activated receptor delta antagonist | 0.065 0.007 DBMET01437 0.035 0.019 DBMET00507 | DBMET01437 | |
| 0.015 | 0.141 | 0.039 | Protein kinase C beta II inhibitor | 0.039 0.012 DBMET01437 | DBMET01437 | |
| 0.008 | 0.137 | 0.047 | Leukotriene D4 antagonist | 0.047 0.01 DBMET01437 | DBMET01437 | |
| 0.009 | 0.138 | 0.036 | Trypsin I inhibitor | 0.036 0.02 DBMET00507 | DBMET00507 | |
| 0.051 | 0.181 | 0.098 | Alpha 2c adrenoreceptor antagonist | 0.098 0.067 DBMET03364 | DBMET03364 | |
| 0.065 | 0.196 | 0.118 | Nav1.5 sodium channel blocker | 0.118 0.057 DBMET03364 | DBMET03364 | |
| 0.012 | 0.147 | 0.093 | Glycine transporter inhibitor | 0.093 0.013 DBMET00507 | DBMET00507 | |
| 0.062 | 0.199 | 0.126 | Toll-Like receptor 9 antagonist | 0.126 0.08 DBMET03364 | DBMET03364 | |
| 0.05 | 0.187 | 0.114 | Glycogen synthase kinase-3 alpha inhibitor | 0.114 0.089 DBMET01437 | DBMET01437 | |
| 0.02 | 0.159 | 0.067 | Nicotinic neuronal receptor agonist | 0.067 0.03 DBMET03364 | DBMET03364 | |
| 0.055 | 0.199 | 0.123 | MAP kinase kinase inhibitor | 0.117 0.076 DBMET01437 0.123 0.071 DBMET03364 | DBMET03364 | |
| 0.006 | 0.151 | 0.025 | Kainate receptor 3 antagonist | 0.025 0.007 DBMET01437 | DBMET01437 | |
| 0.021 | 0.168 | 0.134 | Selectin antagonist | 0.134 0.02 DBMET01436 0.113 0.024 DBMET01437 0.111 0.024 DBMET00507 | DBMET01436 | |
| 0.038 | 0.187 | 0.104 | Acetylcholine agonist | 0.104 0.044 DBMET03364 | DBMET03364 | |
| 0.018 | 0.169 | 0.12 | Nicotinic acid receptor 1 agonist | 0.12 0.006 DBMET01437 | DBMET01437 | |
| 0.039 | 0.191 | 0.191 | M18 aspartyl aminopeptidase inhibitor | 0.12 0.071 DBMET01436 0.191 0.036 DBMET01437 | DBMET01437 | |
| 0.023 | 0.175 | 0.037 | Glucose-6-phosphate dehydrogenase inhibitor | 0.037 0.028 DBMET00507 | DBMET00507 | |
| 0.076 | 0.228 | 0.152 | Heat shock protein 90 antagonist | 0.152 0.072 DBMET01436 0.13 0.098 DBMET01437 0.137 0.088 DBMET03364 | DBMET01436 | |
| 0.02 | 0.173 | 0.051 | 5 Hydroxytryptamine 6 antagonist | 0.051 0.047 DBMET03364 | DBMET03364 | |
| 0.018 | 0.174 | 0.032 | Tubulin agonist | 0.032 0.029 DBMET03364 | DBMET03364 | |
| 0.02 | 0.177 | 0.033 | HCV polyprotein inhibitor | 0.033 0.025 DBMET01437 0.032 0.031 DBMET00507 | DBMET01437 | |
| 0.004 | 0.161 | 0.02 | Neutral endopeptidase inhibitor | 0.02 0.015 DBMET00507 | DBMET00507 | |
| 0.047 | 0.204 | 0.113 | Alpha 2b adrenoreceptor antagonist | 0.113 0.063 DBMET03364 | DBMET03364 | |
| 0.017 | 0.176 | 0.19 | Neuraminidase inhibitor | 0.09 0.019 DBMET01436 0.19 0.004 DBMET01437 | DBMET01437 | |
| 0.027 | 0.192 | 0.07 | Angiotensin-converting enzyme inhibitor | 0.058 0.032 DBMET01437 0.07 0.019 DBMET00507 | DBMET00507 | |
| 0.005 | 0.17 | 0.049 | Angiotensin AT2 receptor antagonist | 0.049 0.01 DBMET01437 | DBMET01437 | |
| 0.052 | 0.219 | 0.166 | Thioredoxin reductase inhibitor | 0.077 0.072 DBMET01436 0.09 0.041 DBMET01437 0.166 0.007 DBMET03364 | DBMET03364 | |
| 0.068 | 0.238 | 0.389 | Dual specificity phosphatase 3 inhibitor | 0.181 0.072 DBMET01436 0.389 0.015 DBMET01437 | DBMET01437 | |
| 0.106 | 0.278 | 0.29 | Thyroid hormone beta antagonist | 0.18 0.173 DBMET01436 0.29 0.093 DBMET00507 | DBMET00507 | |
| 0.037 | 0.21 | 0.055 | Lipocortins synthesis agonist | 0.055 0.05 DBMET01437 | DBMET01437 | |
| 0.105 | 0.279 | 0.309 | Thyroid hormone antagonist | 0.188 0.172 DBMET01436 0.19 0.171 DBMET01437 0.309 0.089 DBMET00507 | DBMET00507 | |
| 0.127 | 0.301 | 0.303 | DNA polymerase beta inhibitor | 0.241 0.198 DBMET01436 0.303 0.164 DBMET01437 0.219 0.211 DBMET00507 | DBMET01437 | |
| 0.075 | 0.25 | 0.397 | Dual specificity phosphatase inhibitor | 0.174 0.071 DBMET01436 0.397 0.015 DBMET01437 | DBMET01437 | |
| 0.022 | 0.202 | 0.097 | Guanylate cyclase stimulant | 0.061 0.014 DBMET01436 0.097 0.006 DBMET01437 | DBMET01437 | |
| 0.026 | 0.206 | 0.081 | Phosphodiesterase IV inhibitor | 0.081 0.061 DBMET03364 | DBMET03364 | |
| 0.102 | 0.283 | 0.391 | Catenin beta inhibitor | 0.391 0.004 DBMET01436 0.249 0.011 DBMET01437 0.164 0.076 DBMET00507 | DBMET01436 | |
| 0.024 | 0.205 | 0.064 | Histone deacetylase inhibitor | 0.064 0.047 DBMET00507 | DBMET00507 | |
| 0.005 | 0.188 | 0.039 | Squalene synthetase inhibitor | 0.039 0.018 DBMET01437 | DBMET01437 | |
| 0.032 | 0.216 | 0.322 | Protein-tyrosine phosphatase 1B inhibitor | 0.219 0.024 DBMET01436 0.322 0.009 DBMET01437 | DBMET01437 | |
| 0.016 | 0.2 | 0.058 | Dopamine transporter inhibitor | 0.058 0.026 DBMET03364 | DBMET03364 | |
| 0.035 | 0.22 | 0.081 | Caspase 9 inhibitor | 0.081 0.023 DBMET00507 | DBMET00507 | |
| 0.022 | 0.207 | 0.073 | Alpha adrenoreceptor agonist | 0.073 0.043 DBMET03364 | DBMET03364 | |
| 0.05 | 0.235 | 0.106 | Sodium channel (voltage-gated) blocker | 0.106 0.103 DBMET03364 | DBMET03364 | |
| 0.031 | 0.217 | 0.084 | MAP kinase kinase kinase inhibitor | 0.084 0.082 DBMET03364 | DBMET03364 | |
| 0.019 | 0.206 | 0.039 | Neurotensin receptor antagonist | 0.039 0.038 DBMET00507 | DBMET00507 | |
| 0.033 | 0.221 | 0.083 | Somatostatin 1 agonist | 0.083 0.048 DBMET01437 | DBMET01437 | |
| 0.083 | 0.274 | 0.127 | Papain-like protease (SARS coronavirus) inhibitor | 0.127 0.066 DBMET00507 | DBMET00507 | |
| 0.138 | 0.333 | 0.322 | Interleukin 2 agonist | 0.212 0.169 DBMET01436 0.322 0.06 DBMET01437 0.296 0.077 DBMET00507 | DBMET01437 | |
| 0.02 | 0.216 | 0.059 | Nitric oxide donor | 0.056 0.055 DBMET01437 0.059 0.051 DBMET00507 | DBMET00507 | |
| 0.124 | 0.324 | 0.234 | Transcription factor inhibitor | 0.231 0.2 DBMET01436 0.234 0.199 DBMET01437 | DBMET01437 | |
| 0.044 | 0.244 | 0.273 | M17 leucyl aminopeptidase inhibitor | 0.116 0.081 DBMET01436 0.273 0.016 DBMET01437 0.255 0.019 DBMET03364 | DBMET01437 | |
| 0.055 | 0.256 | 0.147 | Interleukin 12 antagonist | 0.147 0.013 DBMET03364 | DBMET03364 | |
| 0.004 | 0.206 | 0.032 | Prostaglandin EP3 antagonist | 0.032 0.02 DBMET01437 | DBMET01437 | |
| 0.049 | 0.251 | 0.129 | Interleukin 1b antagonist | 0.129 0.055 DBMET01437 | DBMET01437 | |
| 0.064 | 0.27 | 0.685 | Farnesoid X receptor antagonist | 0.131 0.081 DBMET01436 0.216 0.018 DBMET01437 0.685 0.002 DBMET03364 0.151 0.051 DBMET00507 | DBMET03364 | |
| 0.047 | 0.257 | 0.133 | Interleukin 5 antagonist | 0.087 0.06 DBMET01436 0.133 0.016 DBMET01437 | DBMET01437 | |
| 0.009 | 0.223 | 0.024 | Tryptophan hydroxylase 1 inhibitor | 0.024 0.004 DBMET00507 | DBMET00507 | |
| 0.072 | 0.289 | 0.237 | Antiamyloidogenic | 0.202 0.098 DBMET01436 0.237 0.077 DBMET01437 0.171 0.122 DBMET00507 | DBMET01437 | |
| 0.103 | 0.324 | 0.283 | Alpha-glucosidase inhibitor | 0.218 0.208 DBMET01436 0.283 0.169 DBMET01437 | DBMET01437 | |
| 0.035 | 0.258 | 0.088 | Neuropeptide Y antagonist | 0.088 0.049 DBMET03364 | DBMET03364 | |
| 0.108 | 0.331 | 0.302 | DNA directed DNA polymerase inhibitor | 0.223 0.21 DBMET01436 0.302 0.16 DBMET01437 0.248 0.193 DBMET00507 | DBMET01437 | |
| 0.004 | 0.228 | 0.015 | Thyroid hormone alpha antagonist | 0.015 0.012 DBMET00507 | DBMET00507 | |
| 0.023 | 0.249 | 0.161 | Autotaxin inhibitor | 0.161 0.007 DBMET01437 | DBMET01437 | |
| 0.004 | 0.233 | 0.028 | Integrin beta7 antagonist | 0.028 0.01 DBMET00507 | DBMET00507 | |
| 0.046 | 0.276 | 0.417 | Protein-tyrosine phosphatase inhibitor | 0.272 0.025 DBMET01436 0.417 0.008 DBMET01437 0.149 0.079 DBMET00507 | DBMET01437 | |
| 0.033 | 0.263 | 0.067 | Trypsin inhibitor | 0.058 0.052 DBMET01437 0.067 0.036 DBMET00507 | DBMET00507 | |
| 0.02 | 0.252 | 0.086 | Sphingosine 1-phosphate receptor 5 agonist | 0.078 0.013 DBMET01437 0.086 0.011 DBMET00507 | DBMET00507 | |
| 0.01 | 0.242 | 0.049 | Cyclophilin A inhibitor | 0.049 0.007 DBMET03364 | DBMET03364 | |
| 0.011 | 0.243 | 0.109 | Aldose reductase inhibitor | 0.07 0.027 DBMET01437 0.109 0.016 DBMET00507 | DBMET00507 | |
| 0.048 | 0.28 | 0.189 | Neurotrophic factor | 0.189 0.033 DBMET01436 0.17 0.044 DBMET01437 | DBMET01436 | |
| 0.011 | 0.244 | 0.285 | Prostaglandin antagonist | 0.143 0.011 DBMET01436 0.285 0.005 DBMET01437 0.057 0.034 DBMET00507 | DBMET01437 | |
| 0.023 | 0.257 | 0.1 | Transcription factor AP-1 inhibitor | 0.1 0.013 DBMET01436 0.057 0.051 DBMET01437 | DBMET01436 | |
| 0.008 | 0.244 | 0.029 | Liver X receptor alpha antagonist | 0.029 0.02 DBMET01437 | DBMET01437 | |
| 0.086 | 0.323 | 0.162 | MAP kinase kinase 4 inhibitor | 0.162 0.043 DBMET01437 0.145 0.071 DBMET03364 | DBMET01437 | |
| 0.006 | 0.245 | 0.048 | Prostacyclin antagonist | 0.045 0.015 DBMET01437 0.048 0.014 DBMET00507 | DBMET00507 | |
| 0.005 | 0.247 | 0.023 | Bombesin 3 receptor agonist | 0.023 0.009 DBMET01437 | DBMET01437 | |
| 0.012 | 0.261 | 0.043 | Aminopeptidase N inhibitor | 0.043 0.038 DBMET00507 | DBMET00507 | |
| 0.057 | 0.309 | 0.172 | Anticonvulsant | 0.16 0.117 DBMET01436 0.153 0.126 DBMET01437 0.172 0.105 DBMET03364 0.167 0.11 DBMET00507 | DBMET03364 | |
| 0.008 | 0.266 | 0.029 | Liver X receptor antagonist | 0.029 0.023 DBMET01437 | DBMET01437 | |
| 0.009 | 0.269 | 0.092 | Glutamate (mGluR group II) agonist | 0.044 0.018 DBMET01436 0.092 0.008 DBMET01437 | DBMET01437 | |
| 0.063 | 0.324 | 0.222 | Hepatoprotectant | 0.209 0.06 DBMET01436 0.222 0.053 DBMET01437 0.197 0.067 DBMET00507 | DBMET01437 | |
| 0.006 | 0.267 | 0.566 | Protocollagen prolyl hydroxylase inhibitor | 0.049 0.005 DBMET01437 0.566 0.002 DBMET00507 | DBMET00507 | |
| 0.014 | 0.277 | 0.049 | Elastase inhibitor | 0.049 0.044 DBMET00507 | DBMET00507 | |
| 0.018 | 0.282 | 0.06 | Aminopeptidase microsomal inhibitor | 0.06 0.039 DBMET00507 | DBMET00507 | |
| 0.004 | 0.27 | 0.023 | Endothelin B receptor antagonist | 0.023 0.011 DBMET01437 | DBMET01437 | |
| 0.093 | 0.36 | 0.159 | CC chemokine 6 receptor antagonist | 0.159 0.013 DBMET01437 | DBMET01437 | |
| 0.005 | 0.273 | 0.034 | Kainate receptor 4 antagonist | 0.034 0.012 DBMET01437 | DBMET01437 | |
| 0.005 | 0.273 | 0.027 | Bombesin agonist | 0.027 0.01 DBMET01437 | DBMET01437 | |
| 0.009 | 0.279 | 0.049 | Collagenase inhibitor | 0.049 0.035 DBMET00507 | DBMET00507 | |
| 0.006 | 0.278 | 0.081 | Glutamate (mGluR2) agonist | 0.038 0.019 DBMET01436 0.081 0.008 DBMET01437 | DBMET01437 | |
| 0.009 | 0.282 | 0.082 | Factor XIa inhibitor | 0.082 0.008 DBMET01437 | DBMET01437 | |
| 0.006 | 0.281 | 0.052 | AMPA 2 receptor antagonist | 0.052 0.01 DBMET01437 | DBMET01437 | |
| 0.017 | 0.292 | 0.314 | Leukotriene synthesis inhibitor | 0.314 0.004 DBMET01436 0.12 0.017 DBMET01437 | DBMET01436 | |
| 0.003 | 0.281 | 0.069 | VLA-4 antagonist | 0.069 0.009 DBMET00507 | DBMET00507 | |
| 0.005 | 0.287 | 0.051 | Factor XI inhibitor | 0.051 0.01 DBMET01437 | DBMET01437 | |
| 0.012 | 0.294 | 0.148 | Peroxisome proliferator-activated receptor gamma agonist | 0.08 0.041 DBMET01436 0.148 0.013 DBMET01437 0.098 0.029 DBMET00507 | DBMET01437 | |
| 0.028 | 0.312 | 0.138 | ATPase (Vacuolar H+) inhibitor | 0.138 0.011 DBMET03364 | DBMET03364 | |
| 0.023 | 0.309 | 0.147 | 5-Lipoxygenase inhibitor | 0.107 0.058 DBMET01436 0.147 0.039 DBMET01437 | DBMET01437 | |
| 0.004 | 0.294 | 0.029 | Cholecystokinin B antagonist | 0.029 0.022 DBMET00507 | DBMET00507 | |
| 0.04 | 0.33 | 0.377 | Mcl-1 antagonist | 0.377 0.013 DBMET01437 | DBMET01437 | |
| 0.02 | 0.311 | 0.051 | Integrin alpha1beta1 antagonist | 0.051 0.007 DBMET00507 | DBMET00507 | |
| 0.013 | 0.31 | 0.034 | Cholecystokinin B agonist | 0.034 0.032 DBMET01436 | DBMET01436 | |
| 0.019 | 0.319 | 0.072 | Glucagon-like peptide 1 receptor antagonist | 0.041 0.024 DBMET01437 0.072 0.006 DBMET00507 | DBMET00507 | |
| 0.063 | 0.367 | 0.264 | Antioxidant | 0.256 0.081 DBMET01436 0.264 0.077 DBMET01437 0.175 0.137 DBMET00507 | DBMET01437 | |
| 0.005 | 0.313 | 0.051 | Complement C3a chemotactic receptor antagonist | 0.051 0.026 DBMET00507 | DBMET00507 | |
| 0.053 | 0.367 | 0.158 | P-glycoprotein inhibitor | 0.151 0.115 DBMET01436 0.158 0.105 DBMET01437 | DBMET01437 | |
| 0.006 | 0.321 | 0.019 | Guanylate cyclase 1 stimulant | 0.019 0.014 DBMET01437 | DBMET01437 | |
| 0.008 | 0.329 | 0.223 | Antineoplastic antibiotic | 0.223 0.017 DBMET03364 | DBMET03364 | |
| 0.045 | 0.368 | 0.134 | Hematopoietic | 0.105 0.031 DBMET01437 0.134 0.018 DBMET03364 0.131 0.018 DBMET00507 | DBMET03364 | |
| 0.028 | 0.355 | 0.059 | Bcl-xL inhibitor | 0.059 0.042 DBMET01437 | DBMET01437 | |
| 0.1 | 0.427 | 0.349 | Peptidyltransferase inhibitor | 0.235 0.062 DBMET01437 0.349 0.012 DBMET00507 | DBMET00507 | |
| 0.053 | 0.382 | 0.131 | Interleukin 6 antagonist | 0.131 0.123 DBMET00507 | DBMET00507 | |
| 0.028 | 0.357 | 0.257 | Cell adhesion molecule inhibitor | 0.117 0.025 DBMET01437 0.257 0.006 DBMET03364 0.161 0.013 DBMET00507 | DBMET03364 | |
| 0.014 | 0.343 | 0.074 | Myc inhibitor | 0.074 0.016 DBMET01437 | DBMET01437 | |
| 0.001 | 0.342 | 0.025 | Antibiotic Macrolide-like | 0.025 0.005 DBMET03364 | DBMET03364 | |
| 0.029 | 0.371 | 0.21 | Antineoplastic alkaloid | 0.21 0.011 DBMET03364 | DBMET03364 | |
| 0.004 | 0.351 | 0.019 | Endothelin A receptor antagonist | 0.019 0.017 DBMET01437 | DBMET01437 | |
| 0.003 | 0.353 | 0.057 | Integrin alpha4 antagonist | 0.057 0.01 DBMET00507 | DBMET00507 | |
| 0.016 | 0.367 | 0.056 | DNA gyrase subunit A inhibitor | 0.056 0.013 DBMET01437 | DBMET01437 | |
| 0.004 | 0.361 | 0.032 | Endothelin receptor antagonist | 0.032 0.016 DBMET01437 | DBMET01437 | |
| 0.042 | 0.403 | 0.269 | Amyloid beta precursor protein antagonist | 0.149 0.102 DBMET01436 0.269 0.026 DBMET01437 | DBMET01437 | |
| 0.057 | 0.421 | 0.177 | Growth hormone agonist | 0.177 0.069 DBMET00507 | DBMET00507 | |
| 0.004 | 0.372 | 0.055 | Cholecystokinin antagonist | 0.055 0.022 DBMET00507 | DBMET00507 | |
| 0.034 | 0.403 | 0.101 | Electron transport complex I inhibitor | 0.101 0.08 DBMET00507 | DBMET00507 | |
| 0.091 | 0.46 | 0.409 | Apoptosis antagonist | 0.409 0.036 DBMET01436 0.342 0.06 DBMET01437 0.337 0.062 DBMET00507 | DBMET01436 | |
| 0.025 | 0.397 | 0.403 | Chelator | 0.118 0.055 DBMET01436 0.2 0.024 DBMET01437 0.403 0.005 DBMET00507 | DBMET00507 | |
| 0.006 | 0.383 | 0.028 | Trypsin II inhibitor | 0.028 0.023 DBMET00507 | DBMET00507 | |
| 0.047 | 0.43 | 0.201 | Folate antagonist | 0.119 0.04 DBMET01437 0.201 0.01 DBMET00507 | DBMET00507 | |
| 0.039 | 0.432 | 0.299 | Free radical scavenger | 0.299 0.052 DBMET01436 0.274 0.059 DBMET01437 0.158 0.136 DBMET00507 | DBMET01436 | |
| 0.062 | 0.457 | 0.392 | Hypoglycemic | 0.362 0.035 DBMET01436 0.392 0.029 DBMET01437 0.284 0.059 DBMET00507 | DBMET01437 | |
| 0.034 | 0.439 | 0.303 | Cell adhesion inhibitor | 0.178 0.032 DBMET01437 0.303 0.01 DBMET03364 0.244 0.016 DBMET00507 | DBMET03364 | |
| 0.014 | 0.425 | 0.068 | Nav1.8 sodium channel blocker | 0.068 0.059 DBMET01437 | DBMET01437 | |
| 0.039 | 0.454 | 0.194 | Interleukin 4 antagonist | 0.194 0.024 DBMET01437 | DBMET01437 | |
| 0.024 | 0.438 | 0.106 | Multidrug resistance-associated protein 1 inhibitor | 0.106 0.067 DBMET01437 0.093 0.092 DBMET00507 | DBMET01437 | |
| 0.004 | 0.42 | 0.018 | Integrin alphaLbeta2 antagonist | 0.018 0.005 DBMET00507 | DBMET00507 | |
| 0.003 | 0.422 | 0.035 | Integrin alpha4beta7 antagonist | 0.035 0.007 DBMET00507 | DBMET00507 | |
| 0.01 | 0.434 | 0.047 | VCAM-1 antagonist | 0.047 0.011 DBMET00507 | DBMET00507 | |
| 0.01 | 0.434 | 0.047 | VCAM antagonist | 0.047 0.011 DBMET00507 | DBMET00507 | |
| 0.038 | 0.465 | 0.174 | Histone deacetylase SIRT1 inhibitor | 0.114 0.099 DBMET01437 0.174 0.044 DBMET00507 | DBMET00507 | |
| 0.104 | 0.533 | 0.539 | MAP kinase kinase 6 inhibitor | 0.539 0.011 DBMET03364 | DBMET03364 | |
| 0.004 | 0.441 | 0.041 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.034 0.016 DBMET01437 0.041 0.012 DBMET00507 | DBMET00507 | |
| 0.029 | 0.476 | 0.324 | Hypolipemic | 0.193 0.1 DBMET01436 0.324 0.042 DBMET01437 0.223 0.08 DBMET00507 | DBMET01437 | |
| 0.014 | 0.469 | 0.062 | Sirtuin 1 inhibitor | 0.062 0.056 DBMET00507 | DBMET00507 | |
| 0.079 | 0.535 | 0.414 | Apoptosis agonist | 0.414 0.107 DBMET01436 0.28 0.187 DBMET01437 | DBMET01436 | |
| 0.018 | 0.477 | 0.136 | Cyclooxygenase 1 inhibitor | 0.111 0.089 DBMET01436 0.136 0.066 DBMET01437 | DBMET01437 | |
| 0.016 | 0.493 | 0.087 | Factor IXa inhibitor | 0.087 0.014 DBMET01437 | DBMET01437 | |
| 0.005 | 0.481 | 0.019 | Integrin beta6 antagonist | 0.019 0.004 DBMET00507 | DBMET00507 | |
| 0.006 | 0.488 | 0.088 | Glutamate (mGluR) agonist | 0.058 0.047 DBMET01436 0.088 0.027 DBMET01437 | DBMET01437 | |
| 0.054 | 0.539 | 0.128 | Sphingosine 1-phosphate receptor 2 agonist | 0.128 0.044 DBMET00507 | DBMET00507 | |
| 0.03 | 0.518 | 0.112 | Interleukin 1 antagonist | 0.112 0.101 DBMET01437 | DBMET01437 | |
| 0.003 | 0.494 | 0.021 | Integrin beta3 antagonist | 0.021 0.012 DBMET00507 | DBMET00507 | |
| 0.014 | 0.546 | 0.083 | Protease inhibitor | 0.083 0.082 DBMET00507 | DBMET00507 | |
| 0.016 | 0.55 | 0.18 | Lipid peroxidase inhibitor | 0.18 0.05 DBMET01436 0.137 0.078 DBMET01437 | DBMET01436 | |
| 0.017 | 0.554 | 0.135 | Histone deacetylase class III inhibitor | 0.135 0.057 DBMET00507 | DBMET00507 | |
| 0.003 | 0.543 | 0.118 | GP IIb/IIIa receptor antagonist | 0.118 0.014 DBMET00507 | DBMET00507 | |
| 0.009 | 0.551 | 0.028 | DNA topoisomerase IV inhibitor | 0.028 0.025 DBMET01437 | DBMET01437 | |
| 0.008 | 0.551 | 0.071 | Lipase inhibitor | 0.071 0.053 DBMET01437 | DBMET01437 | |
| 0.028 | 0.576 | 0.119 | CDK3/cyclin E inhibitor | 0.119 0.057 DBMET00507 | DBMET00507 | |
| 0.005 | 0.554 | 0.039 | Macrophage elastase inhibitor | 0.039 0.035 DBMET00507 | DBMET00507 | |
| 0.004 | 0.556 | 0.038 | Integrin alphaVbeta3 antagonist | 0.038 0.005 DBMET00507 | DBMET00507 | |
| 0.004 | 0.56 | 0.162 | Integrin antagonist | 0.162 0.009 DBMET00507 | DBMET00507 | |
| 0.008 | 0.579 | 0.434 | Erythropoietin receptor agonist | 0.434 0.004 DBMET00507 | DBMET00507 | |
| 0.035 | 0.607 | 0.327 | Immunosuppressant | 0.292 0.12 DBMET01436 0.327 0.099 DBMET01437 0.24 0.157 DBMET00507 | DBMET01437 | |
| 0.016 | 0.591 | 0.282 | Thrombolytic | 0.156 0.077 DBMET01436 0.222 0.042 DBMET01437 0.282 0.027 DBMET00507 | DBMET00507 | |
| 0.005 | 0.582 | 0.076 | Glucagon-like peptide 1 agonist | 0.076 0.037 DBMET00507 | DBMET00507 | |
| 0.011 | 0.603 | 0.068 | Topoisomerase II alpha inhibitor | 0.068 0.064 DBMET00507 | DBMET00507 | |
| 0.005 | 0.604 | 0.096 | Phosphodiesterase 4D inhibitor | 0.096 0.038 DBMET03364 | DBMET03364 | |
| 0.019 | 0.625 | 0.249 | Streptokinase A inhibitor | 0.249 0.103 DBMET01437 | DBMET01437 | |
| 0.009 | 0.635 | 0.277 | Cyclooxygenase 2 inhibitor | 0.277 0.016 DBMET03364 | DBMET03364 | |
| 0.022 | 0.655 | 0.124 | MAP3K9 inhibitor | 0.124 0.106 DBMET01437 | DBMET01437 | |
| 0.007 | 0.641 | 0.062 | Plasminogen activator inhibitor | 0.062 0.038 DBMET00507 | DBMET00507 | |
| 0.005 | 0.64 | 0.073 | Integrin alpha5beta1 antagonist | 0.073 0.008 DBMET00507 | DBMET00507 | |
| 0.012 | 0.656 | 0.267 | Cyclooxygenase inhibitor | 0.267 0.023 DBMET03364 | DBMET03364 | |
| 0.015 | 0.659 | 0.2 | Thioredoxin glutathione reductase inhibitor | 0.2 0.172 DBMET01437 | DBMET01437 | |
| 0.003 | 0.662 | 0.045 | Vitronectin receptor antagonist | 0.045 0.007 DBMET00507 | DBMET00507 | |
| 0.008 | 0.672 | 0.049 | Protein 50S ribosomal subunit inhibitor | 0.049 0.041 DBMET03364 | DBMET03364 | |
| 0.017 | 0.685 | 0.266 | Insulin secretagoues | 0.266 0.017 DBMET01437 0.197 0.038 DBMET00507 | DBMET01437 | |
| 0.011 | 0.69 | 0.373 | Platelet antagonist | 0.244 0.075 DBMET01436 0.303 0.052 DBMET01437 0.373 0.033 DBMET00507 | DBMET00507 | |
| 0.013 | 0.693 | 0.183 | Bone formation stimulant | 0.131 0.076 DBMET01437 0.183 0.041 DBMET00507 | DBMET00507 | |
| 0.013 | 0.695 | 0.14 | Acetylcholine M3 receptor agonist | 0.14 0.024 DBMET03364 | DBMET03364 | |
| 0.006 | 0.691 | 0.114 | DNA gyrase inhibitor | 0.072 0.034 DBMET01436 0.114 0.014 DBMET01437 | DBMET01437 | |
| 0.004 | 0.723 | 0.062 | Phosphodiesterase 4A inhibitor | 0.062 0.029 DBMET03364 | DBMET03364 | |
| 0.008 | 0.732 | 0.088 | Aminoacyl-tRNA synthetase inhibitor | 0.086 0.065 DBMET01437 0.088 0.063 DBMET00507 | DBMET00507 | |
| 0.016 | 0.741 | 0.057 | Gonadotropin-releasing hormone receptor agonist | 0.057 0.046 DBMET00507 | DBMET00507 | |
| 0.018 | 0.743 | 0.161 | Platelet adhesion inhibitor | 0.161 0.094 DBMET01437 0.148 0.108 DBMET00507 | DBMET01437 | |
| 0.012 | 0.739 | 0.218 | Vasodilator | 0.218 0.091 DBMET01437 | DBMET01437 | |
| 0.003 | 0.744 | 0.031 | Integrin alphaVbeta1 antagonist | 0.031 0.005 DBMET00507 | DBMET00507 | |
| 0.006 | 0.771 | 0.173 | Topoisomerase II inhibitor | 0.173 0.04 DBMET01437 | DBMET01437 | |
| 0.005 | 0.81 | 0.077 | Thrombin inhibitor | 0.077 0.046 DBMET00507 | DBMET00507 | |
| 0.007 | 0.815 | 0.074 | MAP3K7 inhibitor | 0.074 0.048 DBMET03364 | DBMET03364 | |
| 0.007 | 0.816 | 0.224 | DNA intercalator | 0.224 0.02 DBMET01436 | DBMET01436 | |
| 0.004 | 0.82 | 0.051 | Acetylcholine M2 receptor agonist | 0.051 0.042 DBMET03364 | DBMET03364 | |
| 0.025 | 0.843 | 0.157 | Growth factor agonist | 0.157 0.127 DBMET00507 | DBMET00507 | |
| 0.005 | 0.854 | 0.165 | Glutamate receptor antagonist | 0.165 0.041 DBMET01437 | DBMET01437 | |
| 0.005 | 0.884 | 0.287 | Anticoagulant | 0.121 0.11 DBMET01437 0.287 0.031 DBMET00507 | DBMET00507 | |
| 0.002 | 0.89 | 0.037 | Glycine transporter 1 inhibitor | 0.037 0.023 DBMET00507 | DBMET00507 | |
| 0.003 | 0.906 | 0.249 | Neuropeptide Y5 antagonist | 0.249 0.005 DBMET03364 | DBMET03364 | |
| 0.008 | 0.934 | 0.071 | Phosphodiesterase VIII inhibitor | 0.071 0.052 DBMET03364 | DBMET03364 | |
| 0.005 | 0.932 | 0.177 | DNA directed RNA polymerase inhibitor | 0.177 0.017 DBMET03364 | DBMET03364 | |
| 0.003 | 0.953 | 0.193 | CDK4/cyclin D inhibitor | 0.193 0.005 DBMET03364 | DBMET03364 | |
| 0.004 | 0.962 | 0.17 | Platelet aggregation inhibitor | 0.17 0.107 DBMET00507 | DBMET00507 | |
| 0.003 | 0.966 | 0.199 | CDK/cyclin complex inhibitor | 0.199 0.019 DBMET03364 | DBMET03364 | |
| 0.005 | 0.971 | 0.558 | Cardiotonic | 0.227 0.098 DBMET01436 0.558 0.01 DBMET03364 0.182 0.138 DBMET00507 | DBMET03364 | |
| 0.005 | 0.979 | 0.35 | Analgesic | 0.35 0.109 DBMET03364 | DBMET03364 | |
| 0.004 | 0.981 | 0.267 | Toll-Like receptor 7 agonist | 0.267 0.133 DBMET03364 | DBMET03364 | |
| 0.005 | 0.982 | 0.525 | Cyclophilin D inhibitor | 0.399 0.092 DBMET01436 0.525 0.043 DBMET01437 0.425 0.078 DBMET00507 | DBMET01437 | |
| 0.004 | 0.982 | 0.259 | Toll-Like receptor agonist | 0.259 0.14 DBMET03364 | DBMET03364 | |
| 0.005 | 0.988 | 0.237 | Immunomodulator | 0.237 0.125 DBMET03364 | DBMET03364 | |
| 0.005 | 0.989 | 0.584 | Antiinflammatory | 0.393 0.143 DBMET01436 0.406 0.136 DBMET01437 0.584 0.058 DBMET03364 | DBMET03364 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |